ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
GO:0035329,hippo signaling,14/87,54/13083,0.25925925925925924,38.98722860791826,22.88604753310294,2.904008352963552e-19,7.283252949232588e-16,4.866506629387341e-16,NF2/AMOTL2/NUAK2/LATS2/SCHIP1/TEAD1/AMOTL1/AMOT/WWC2/FRMD6/ARRDC3/WWTR1/YAP1/STK3,14
GO:0007178,cell surface receptor protein serine/threonine kinase signaling pathway,19/87,304/13083,0.0625,9.398706896551724,12.122512185630626,8.686845068509549e-14,1.0893303715910975e-10,7.278661762666948e-11,TET1/CRIM1/LATS2/DAB2/CCN1/INHBA/FSTL1/TGFB2/THBS1/ITGB5/SMAD7/UBE2D1/SMAD2/SMAD3/USP9X/RUNX2/WWTR1/SMAD6/SMAD1,19
GO:0045667,regulation of osteoblast differentiation,13/87,110/13083,0.11818181818181818,17.772100313479626,14.452914454923398,3.0947946091754397e-13,2.2323406441624536e-10,1.4916000610705219e-10,CRIM1/CCN1/JAG1/FGF2/TP63/SMAD3/RUNX2/GSK3B/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,13
GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,18/87,285/13083,0.06315789473684211,9.497640653357532,11.867017593651047,3.560351904565317e-13,2.2323406441624536e-10,1.4916000610705219e-10,TET1/CRIM1/LATS2/DAB2/CCN1/INHBA/FSTL1/TGFB2/THBS1/ITGB5/SMAD7/UBE2D1/SMAD2/SMAD3/USP9X/RUNX2/SMAD6/SMAD1,18
GO:0048729,tissue morphogenesis,21/87,481/13083,0.04365904365904366,6.565416875761704,10.175185806130987,3.876321327177157e-12,1.944362777712062e-9,1.2991796953402176e-9,NF2/CCN1/MYC/INHBA/JAG1/TGFB2/FGF2/SLIT2/DLC1/TGM2/ITGB5/SMAD7/SMAD2/TP63/SMAD3/FAT1/EGFR/CTNNB1/YAP1/SMAD1/STK3,21
GO:0001503,ossification,18/87,349/13083,0.05157593123209169,7.755952969074202,10.466675399268198,1.0907048023659483e-11,4.559146073889664e-9,3.046319377836122e-9,RUNX1/CRIM1/IGFBP3/CCN2/CCN1/JAG1/FGF2/SMAD7/TP63/SMAD3/RUNX2/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,18
GO:0072073,kidney epithelium development,12/87,117/13083,0.10256410256410256,15.423519009725906,12.821918169999392,1.4884010135187804e-11,5.332728202721573e-9,3.5632096443938314e-9,MYC/JAG1/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,12
GO:1902895,positive regulation of miRNA transcription,9/87,48/13083,0.1875,28.19612068965517,15.444146340132855,2.259359125098686e-11,7.08309085718438e-9,4.732762798890931e-9,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0060395,SMAD protein signal transduction,10/87,72/13083,0.1388888888888889,20.8860153256705,13.843647327353615,3.810558533219086e-11,8.697074459496126e-9,5.811190522755742e-9,DAB2/INHBA/TGFB2/SMAD7/SMAD2/SMAD3/RUNX2/WWTR1/SMAD6/SMAD1,10
GO:0040008,regulation of growth,20/87,485/13083,0.041237113402061855,6.201208674013508,9.550281938945059,3.864922436985077e-11,8.697074459496126e-9,5.811190522755742e-9,RUNX1/IGFBP3/CDK1/LATS2/DAB2/INHBA/TGFB2/FGF2/SLIT2/SGK1/SMAD7/TEAD1/SMAD3/GSK3B/WWC2/EGFR/CREB1/SMARCA2/YAP1/STK3,20
GO:0001649,osteoblast differentiation,14/87,197/13083,0.07106598984771574,10.686854542272012,11.208530433881586,4.000924604687802e-11,8.697074459496126e-9,5.811190522755742e-9,CRIM1/IGFBP3/CCN1/JAG1/FGF2/TP63/SMAD3/RUNX2/GSK3B/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,14
GO:0007507,heart development,20/87,487/13083,0.04106776180698152,6.175741697939531,9.523851085372325,4.1612796456919265e-11,8.697074459496126e-9,5.811190522755742e-9,RUNX1/CDK1/CCN1/INHBA/JAG1/BICC1/TGFB2/FGF2/SLIT2/DLC1/SMAD7/SMAD2/SMAD3/EGFR/CTNNB1/CREB1/YAP1/SMAD6/SMAD1/STK3,20
GO:2000630,positive regulation of miRNA metabolic process,9/87,55/13083,0.16363636363636364,24.607523510971788,14.35439021404819,8.248892670382375e-11,1.5914017551783846e-8,1.0633390389675094e-8,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0001822,kidney development,15/87,255/13083,0.058823529411764705,8.845841784989858,10.351946243632314,1.1115342152877689e-10,1.991234151386946e-8,1.3304980982993442e-8,CENPF/MYC/JAG1/BICC1/TGFB2/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,15
GO:0072001,renal system development,15/87,260/13083,0.057692307692307696,8.675729442970823,10.22829766397695,1.4608691327896364e-10,2.442573190024272e-8,1.632072743439369e-8,CENPF/MYC/JAG1/BICC1/TGFB2/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,15
GO:0045669,positive regulation of osteoblast differentiation,9/87,60/13083,0.15,22.556896551724137,13.692986812620541,1.8668772245971743e-10,2.815973614016545e-8,1.8815705504551077e-8,CCN1/JAG1/FGF2/TP63/RUNX2/CTNNB1/WWTR1/YAP1/SMAD1,9
GO:0090287,regulation of cellular response to growth factor stimulus,15/87,265/13083,0.05660377358490566,8.512036434612883,10.107932576940984,1.9087540445885673e-10,2.815973614016545e-8,1.8815705504551077e-8,TET1/CRIM1/LATS2/CCN1/FSTL1/FGF2/SLIT2/THBS1/SMAD7/UBE2D1/SMAD2/SMAD3/RUNX2/CTNNB1/SMAD6,15
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,14/87,227/13083,0.06167400881057269,9.27449491113474,10.28947786623751,2.648267969746727e-10,3.6899200378471066e-8,2.465521992887011e-8,TET1/CRIM1/LATS2/DAB2/CCN1/INHBA/FSTL1/TGFB2/THBS1/SMAD7/UBE2D1/SMAD2/SMAD3/SMAD6,14
GO:0001525,angiogenesis,18/87,433/13083,0.04157043879907621,6.251333917336943,9.092015501419032,3.7563026787667337e-10,4.9583195359720884e-8,3.313038152131102e-8,RUNX1/AMOTL2/CCN2/CCN1/ETS1/JAG1/GADD45A/SERPINE1/TGFB2/DDAH1/FGF2/SLIT2/THBS1/TGM2/AMOTL1/AMOT/CTNNB1/SMAD1,18
GO:1902893,regulation of miRNA transcription,9/87,66/13083,0.13636363636363635,20.50626959247649,12.998181140845611,4.5256107951853284e-10,5.6751159371624023e-8,3.791985466281601e-8,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0061614,miRNA transcription,9/87,67/13083,0.13432835820895522,20.200205867215647,12.891289576434776,5.199768653514058e-10,6.210009420482504e-8,4.149389321500941e-8,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0001657,ureteric bud development,9/87,75/13083,0.12,18.04551724137931,12.112321761236055,1.462929035898429e-9,1.667739100924209e-7,1.1143459450479897e-7,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0072163,mesonephric epithelium development,9/87,76/13083,0.11842105263157894,17.808076225045372,12.023421778925215,1.6505239016228554e-9,1.724797477195884e-7,1.1524710751682393e-7,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0072164,mesonephric tubule development,9/87,76/13083,0.11842105263157894,17.808076225045372,12.023421778925215,1.6505239016228554e-9,1.724797477195884e-7,1.1524710751682393e-7,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0001823,mesonephros development,9/87,77/13083,0.11688311688311688,17.57680250783699,11.936200313911925,1.8589314394647768e-9,1.864880020071064e-7,1.2460710954222838e-7,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:2000628,regulation of miRNA metabolic process,9/87,78/13083,0.11538461538461539,17.351458885941646,11.850603759563889,2.0901073894610626e-9,2.0161497433724406e-7,1.3471461392801665e-7,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0048598,embryonic morphogenesis,18/87,485/13083,0.03711340206185567,5.581087806612158,8.411637156339921,2.3016284527913077e-9,2.0633358709029084e-7,1.378674853721745e-7,NF2/LATS2/CCN1/INHBA/ETS2/TGFB2/FGF2/DLC1/ITGB5/SMAD2/TP63/SMAD3/RUNX2/AMOT/CTNNB1/YAP1/SMAD1/STK3,18
GO:0007179,transforming growth factor beta receptor signaling pathway,12/87,180/13083,0.06666666666666667,10.025287356321838,9.975709406171143,2.3035647681531673e-9,2.0633358709029084e-7,1.378674853721745e-7,TET1/LATS2/DAB2/TGFB2/THBS1/ITGB5/SMAD7/SMAD2/SMAD3/USP9X/SMAD6/SMAD1,12
GO:0043065,positive regulation of apoptotic process,17/87,442/13083,0.038461538461538464,5.783819628647215,8.371187371881842,4.020277836031106e-9,3.476847176815867e-7,2.3231514754851255e-7,IGFBP3/LATS2/CCN1/MYC/INHBA/GADD45B/GADD45A/TGFB2/SLIT2/THBS1/DLC1/TGM2/TP63/GSK3B/CTNNB1/TP53BP2/STK3,17
GO:0035330,regulation of hippo signaling,7/87,38/13083,0.18421052631578946,27.701451905626136,13.486413802335298,4.8046408792607825e-9,4.016679775062014e-7,2.683855536766023e-7,NF2/NUAK2/SCHIP1/WWC2/FRMD6/ARRDC3/STK3,7
GO:0043068,positive regulation of programmed cell death,17/87,455/13083,0.03736263736263736,5.618567639257295,8.204225095004572,6.2066655432779265e-9,5.021392639529368e-7,3.3551821884205284e-7,IGFBP3/LATS2/CCN1/MYC/INHBA/GADD45B/GADD45A/TGFB2/SLIT2/THBS1/DLC1/TGM2/TP63/GSK3B/CTNNB1/TP53BP2/STK3,17
GO:0002009,morphogenesis of an epithelium,16/87,401/13083,0.0399002493765586,6.0001719838335195,8.320608759169936,7.290597599692958e-9,5.714005868759356e-7,3.817970848260259e-7,CCN1/MYC/JAG1/TGFB2/FGF2/SLIT2/DLC1/TGM2/ITGB5/TP63/SMAD3/FAT1/EGFR/CTNNB1/YAP1/STK3,16
GO:0030509,BMP signaling pathway,10/87,123/13083,0.08130081300813008,12.22596019063639,10.234471009012886,8.102845302911123e-9,6.158162430212453e-7,4.11474632288182e-7,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/USP9X/RUNX2/SMAD6/SMAD1,10
GO:0071772,response to BMP,10/87,129/13083,0.07751937984496124,11.657310879444,9.952504685720008,1.2859990177304833e-8,9.215101532765864e-7,6.157324620231366e-7,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/USP9X/RUNX2/SMAD6/SMAD1,10
GO:0071773,cellular response to BMP stimulus,10/87,129/13083,0.07751937984496124,11.657310879444,9.952504685720008,1.2859990177304833e-8,9.215101532765864e-7,6.157324620231366e-7,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/USP9X/RUNX2/SMAD6/SMAD1,10
GO:0010586,miRNA metabolic process,9/87,96/13083,0.09375,14.098060344827585,10.538529864478928,1.3486075729448876e-8,9.395299424849384e-7,6.277728819088482e-7,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0010717,regulation of epithelial to mesenchymal transition,9/87,99/13083,0.09090909090909091,13.670846394984327,10.354063339364739,1.7716628724093936e-8,1.1631165875664404e-6,7.771684745260525e-7,DAB2/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1,9
GO:0040013,negative regulation of locomotion,13/87,263/13083,0.049429657794676805,7.43319784974433,8.622885456885713,1.7723271216994693e-8,1.1631165875664404e-6,7.771684745260525e-7,TET1/NF2/IGFBP3/JAG1/GADD45A/SERPINE1/FGF2/SLIT2/THBS1/DLC1/SMAD7/GSK3B/ARRDC3,13
GO:0043408,regulation of MAPK cascade,17/87,489/13083,0.034764826175869123,5.2279105845850085,7.796330231133627,1.8086741194214982e-8,1.1631165875664404e-6,7.771684745260525e-7,NF2/IGFBP3/CCN2/DAB2/CCN1/MYC/INHBA/GADD45B/GADD45A/TGFB2/FGF2/THBS1/MDFIC/TAOK1/EGFR/CTNNB1/STK3,17
GO:0045765,regulation of angiogenesis,12/87,224/13083,0.05357142857142857,8.056034482758621,8.715111602551447,2.7067652078843563e-8,1.655748083261943e-6,1.106333815392014e-6,RUNX1/ETS1/GADD45A/SERPINE1/TGFB2/DDAH1/FGF2/THBS1/TGM2/AMOT/CTNNB1/SMAD1,12
GO:0071560,cellular response to transforming growth factor beta stimulus,12/87,224/13083,0.05357142857142857,8.056034482758621,8.715111602551447,2.7067652078843563e-8,1.655748083261943e-6,1.106333815392014e-6,TET1/LATS2/DAB2/TGFB2/THBS1/ITGB5/SMAD7/SMAD2/SMAD3/USP9X/SMAD6/SMAD1,12
GO:0035265,organ growth,10/87,140/13083,0.07142857142857142,10.741379310344827,9.481102546491265,2.8274808665445338e-8,1.6884100031651644e-6,1.1281577793330569e-6,RUNX1/CDK1/LATS2/TGFB2/FGF2/SMAD2/WWC2/YAP1/SMAD1/STK3,10
GO:0003184,pulmonary valve morphogenesis,5/87,15/13083,0.3333333333333333,50.12643678160919,15.575721714483397,3.299147443896044e-8,1.9242469277421574e-6,1.2857387345612e-6,JAG1/TGFB2/SLIT2/SMAD2/SMAD6,5
GO:0071559,response to transforming growth factor beta,12/87,229/13083,0.05240174672489083,7.88013853335341,8.593847123178824,3.4575630200914156e-8,1.9708109214521068e-6,1.316851753106587e-6,TET1/LATS2/DAB2/TGFB2/THBS1/ITGB5/SMAD7/SMAD2/SMAD3/USP9X/SMAD6/SMAD1,12
GO:1901342,regulation of vasculature development,12/87,230/13083,0.05217391304347826,7.845877061469265,8.570035233227383,3.628413333724176e-8,2.0222356979956077e-6,1.3512126379623131e-6,RUNX1/ETS1/GADD45A/SERPINE1/TGFB2/DDAH1/FGF2/THBS1/TGM2/AMOT/CTNNB1/SMAD1,12
GO:0016049,cell growth,15/87,395/13083,0.0379746835443038,5.710606721955479,7.778048693599331,4.3899588238462403e-8,2.39348189787095e-6,1.5992710406323144e-6,IGFBP3/DAB2/INHBA/TGFB2/SLIT2/SGK1/SMAD7/TEAD1/SMAD3/USP9X/GSK3B/EGFR/CTNNB1/SMARCA2/YAP1,15
GO:0050678,regulation of epithelial cell proliferation,13/87,285/13083,0.0456140350877193,6.859407138535996,8.18270511049411,4.586121819299931e-8,2.4472326644264315e-6,1.635186099960916e-6,DAB2/MYC/JAG1/TGFB2/FGF2/THBS1/TP63/SMAD3/RUNX2/EGFR/CTNNB1/YAP1/STK3,13
GO:0010718,positive regulation of epithelial to mesenchymal transition,7/87,52/13083,0.1346153846153846,20.24336870026525,11.375899529130443,4.724831109887183e-8,2.4687242549160533e-6,1.6495462997676301e-6,DAB2/JAG1/TGFB2/SMAD2/SMAD3/CTNNB1/WWTR1,7
GO:0030336,negative regulation of cell migration,12/87,238/13083,0.05042016806722689,7.582150101419878,8.384574992540871,5.29221484401865e-8,2.7087499650609744e-6,1.8099261077717918e-6,TET1/NF2/IGFBP3/JAG1/GADD45A/SERPINE1/FGF2/SLIT2/THBS1/DLC1/SMAD7/GSK3B,12
GO:0050673,epithelial cell proliferation,14/87,344/13083,0.040697674418604654,6.1200882117081,7.8737358912244115,5.529936212459167e-8,2.773816004169518e-6,1.8534017789968407e-6,IGFBP3/DAB2/MYC/JAG1/TGFB2/FGF2/THBS1/TP63/SMAD3/RUNX2/EGFR/CTNNB1/YAP1/STK3,14
GO:2000146,negative regulation of cell motility,12/87,248/13083,0.04838709677419355,7.276418242491657,8.16453823675432,8.315569990426761e-8,4.034065614976148e-6,2.695472365920434e-6,TET1/NF2/IGFBP3/JAG1/GADD45A/SERPINE1/FGF2/SLIT2/THBS1/DLC1/SMAD7/GSK3B,12
GO:0031589,cell-substrate adhesion,13/87,300/13083,0.043333333333333335,6.516436781609196,7.908511050518104,8.364091386712906e-8,4.034065614976148e-6,2.695472365920434e-6,NF2/CCN2/DAB2/CCN1/JAG1/SERPINE1/THBS1/DLC1/ITGB5/SMAD3/GSK3B/CTNNB1/SMAD6,13
GO:0061035,regulation of cartilage development,7/87,57/13083,0.12280701754385964,18.467634603750753,10.813289662121607,9.090203016270764e-8,4.301552672605108e-6,2.8742012317583027e-6,CCN2/CCN1/SMAD7/SMAD3/RUNX2/CTNNB1/SMAD1,7
GO:0003007,heart morphogenesis,11/87,203/13083,0.054187192118226604,8.148632580261594,8.398561580632082,9.573842625318478e-8,4.446518019314582e-6,2.971063832262576e-6,CCN1/JAG1/TGFB2/SLIT2/DLC1/SMAD7/SMAD2/SMAD3/CTNNB1/YAP1/SMAD6,11
GO:0001501,skeletal system development,15/87,421/13083,0.035629453681710214,5.357932672618561,7.436391693285314,1.012572802317586e-7,4.617331978568193e-6,3.08519789720497e-6,RUNX1/CCN2/CCN1/ETS2/TGFB2/FGF2/TGM2/HEXB/SMAD7/SMAD2/TP63/SMAD3/RUNX2/CTNNB1/SMAD1,15
GO:0003177,pulmonary valve development,5/87,19/13083,0.2631578947368421,39.57350272232305,13.766376384861703,1.251007028361803e-7,5.6027243341632174e-6,3.7436150172029887e-6,JAG1/TGFB2/SLIT2/SMAD2/SMAD6,5
GO:0033002,muscle cell proliferation,10/87,171/13083,0.05847953216374269,8.794111716071788,8.393822289916674,1.8791630722168483e-7,8.268317517754132e-6,5.5247047293983786e-6,RUNX1/IGFBP3/CDK1/TGFB2/FGF2/THBS1/EGFR/CTNNB1/YAP1/SMAD1,10
GO:0060828,regulation of canonical Wnt signaling pathway,11/87,219/13083,0.0502283105022831,7.553298693119193,8.00176609777168,2.0656447415098386e-7,8.932132778804612e-6,5.968251231367809e-6,LATS2/DAB2/BICC1/FGF2/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,11
GO:0007498,mesoderm development,8/87,96/13083,0.08333333333333333,12.531609195402298,9.278183539537405,2.270897382031009e-7,9.653238362938593e-6,6.4500778451264335e-6,NF2/INHBA/ETS2/SMAD2/TP63/SMAD3/YAP1/SMAD1,8
GO:0016055,Wnt signaling pathway,14/87,388/13083,0.03608247422680412,5.42605758976182,7.241164573638922,2.4345415207609246e-7,1.0176383556780665e-5,6.799631756230511e-6,AMOTL2/LATS2/DAB2/BICC1/FGF2/MDFIC/AMOTL1/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,14
GO:0001558,regulation of cell growth,13/87,331/13083,0.03927492447129909,5.90613605583915,7.397011263808893,2.609854760488256e-7,1.0730353670991059e-5,7.1697821892964675e-6,IGFBP3/DAB2/INHBA/TGFB2/SLIT2/SGK1/SMAD7/TEAD1/SMAD3/GSK3B/EGFR/SMARCA2/YAP1,13
GO:0060038,cardiac muscle cell proliferation,6/87,41/13083,0.14634146341463414,22.0067283431455,11.02224593451049,2.7093945577889253e-7,1.0959937985378428e-5,7.323185290322528e-6,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:0030111,regulation of Wnt signaling pathway,12/87,279/13083,0.043010752688172046,6.467927326659251,7.553423760407157,2.984053103681045e-7,1.1879373307987398e-5,7.93753139692602e-6,LATS2/DAB2/BICC1/FGF2/MDFIC/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,12
GO:0001704,formation of primary germ layer,8/87,101/13083,0.07920792079207921,11.911232502560601,9.006489393838327,3.3691134744815595e-7,1.2999594759999616e-5,8.686038301821283e-6,NF2/INHBA/ETS2/ITGB5/SMAD2/SMAD3/CTNNB1/SMAD1,8
GO:0002065,columnar/cuboidal epithelial cell differentiation,8/87,101/13083,0.07920792079207921,11.911232502560601,9.006489393838327,3.3691134744815595e-7,1.2999594759999616e-5,8.686038301821283e-6,JAG1/SERPINE1/FGF2/SMAD2/TP63/GSK3B/CTNNB1/YAP1,8
GO:0046620,regulation of organ growth,7/87,74/13083,0.0945945945945946,14.22506989748369,9.334342376945685,5.648377993906992e-7,2.146383637684657e-5,1.434165512966496e-5,RUNX1/CDK1/LATS2/FGF2/WWC2/YAP1/STK3,7
GO:0007160,cell-matrix adhesion,10/87,195/13083,0.05128205128205128,7.711759504862953,7.725965702070613,6.349750167732198e-7,2.3768915553242317e-5,1.588185745016443e-5,NF2/CCN2/JAG1/SERPINE1/THBS1/DLC1/ITGB5/SMAD3/GSK3B/CTNNB1,10
GO:0061036,positive regulation of cartilage development,5/87,26/13083,0.19230769230769232,28.919098143236077,11.658916842028857,6.822536333189625e-7,2.516311929946997e-5,1.68134331926283e-5,CCN1/SMAD7/SMAD3/RUNX2/SMAD1,5
GO:0001837,epithelial to mesenchymal transition,9/87,152/13083,0.05921052631578947,8.904038112522686,8.019487433739728,7.210779565824223e-7,2.6209616160995875e-5,1.751267897603686e-5,DAB2/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1,9
GO:0007369,gastrulation,9/87,157/13083,0.05732484076433121,8.620470019767186,7.859435544114764,9.466264956937693e-7,3.3916275017142474e-5,2.266209595705986e-5,NF2/INHBA/ETS2/ITGB5/SMAD2/SMAD3/AMOT/CTNNB1/SMAD1,9
GO:0001953,negative regulation of cell-matrix adhesion,5/87,28/13083,0.17857142857142858,26.853448275862068,11.204717246559271,1.0087308644229783e-6,3.563235222496943e-5,2.3808740343385934e-5,NF2/JAG1/SERPINE1/THBS1/DLC1,5
GO:0060485,mesenchyme development,11/87,258/13083,0.04263565891472868,6.4115209836942,7.182776618631019,1.0564952834826308e-6,3.6801252374644975e-5,2.4589773264683446e-5,DAB2/MYC/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1/YAP1,11
GO:0003179,heart valve morphogenesis,6/87,52/13083,0.11538461538461539,17.351458885941646,9.666319672948704,1.1571024610001171e-6,3.9753602358743746e-5,2.6562467453672474e-5,CCN1/JAG1/TGFB2/SLIT2/SMAD2/SMAD6,6
GO:0030510,regulation of BMP signaling pathway,7/87,83/13083,0.08433734939759036,12.682592438720398,8.735714730654788,1.2418032194977196e-6,4.166542848728278e-5,2.783990688817014e-5,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/SMAD6,7
GO:0035332,positive regulation of hippo signaling,4/87,13/13083,0.3076923076923077,46.27055702917772,13.361080112515586,1.2459757322752028e-6,4.166542848728278e-5,2.783990688817014e-5,SCHIP1/FRMD6/ARRDC3/STK3,4
GO:0060070,canonical Wnt signaling pathway,11/87,266/13083,0.041353383458646614,6.218693284936479,7.035601723329447,1.425311708661675e-6,4.703528638583528e-5,3.142792576439593e-5,LATS2/DAB2/BICC1/FGF2/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,11
GO:0090288,negative regulation of cellular response to growth factor stimulus,7/87,86/13083,0.08139534883720931,12.2401764234162,8.556430781359161,1.5814487771658304e-6,5.09945550638255e-5,3.407342049089658e-5,CRIM1/FGF2/SLIT2/THBS1/SMAD7/UBE2D1/SMAD6,7
GO:0051216,cartilage development,9/87,167/13083,0.05389221556886228,8.10427421020029,7.559721227304832,1.5859550617936162e-6,5.09945550638255e-5,3.407342049089658e-5,RUNX1/CCN2/CCN1/FGF2/SMAD7/SMAD3/RUNX2/CTNNB1/SMAD1,9
GO:0060411,cardiac septum morphogenesis,6/87,56/13083,0.10714285714285714,16.112068965517242,9.272302276666611,1.806593174380405e-6,5.735361621957032e-5,3.832240284628387e-5,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0043410,positive regulation of MAPK cascade,12/87,334/13083,0.03592814371257485,5.402849473466859,6.669002159992749,2.0030793497732283e-6,6.279653761539071e-5,4.1959241116302355e-5,IGFBP3/CCN2/INHBA/GADD45B/GADD45A/TGFB2/FGF2/THBS1/TAOK1/EGFR/CTNNB1/STK3,12
GO:0042476,odontogenesis,7/87,90/13083,0.07777777777777778,11.69616858237548,8.330798345204228,2.1523568224317193e-06,6.664334457603397e-5,4.452959144004284e-5,NF2/INHBA/SERPINE1/TGFB2/TP63/RUNX2/CTNNB1,7
GO:1904888,cranial skeletal system development,6/87,58/13083,0.10344827586206896,15.556480380499407,9.090198304189766,2.2283176464328734e-6,6.815391045431277e-5,4.5538917755085154e-5,TGFB2/SMAD2/TP63/SMAD3/RUNX2/CTNNB1,6
GO:1900180,regulation of protein localization to nucleus,8/87,130/13083,0.06153846153846154,9.254111405835545,7.738355316306705,2.316270366729748e-6,6.999043469588203e-5,4.676604215388407e-5,NF2/CDK1/LATS2/MDFIC/SMAD3/GSK3B/WWTR1/YAP1,8
GO:0048546,digestive tract morphogenesis,5/87,33/13083,0.15151515151515152,22.784743991640543,10.251703146986479,2.3731368178339436e-6,7.085508498961346e-5,4.7343782130221026e-5,SMAD2/TP63/SMAD3/EGFR/CTNNB1,5
GO:0045766,positive regulation of angiogenesis,8/87,131/13083,0.061068702290076333,9.183469334035271,7.701876255942292,2.453678480077165e-6,7.239794856510035e-5,4.837468904375042e-5,RUNX1/ETS1/SERPINE1/DDAH1/FGF2/THBS1/TGM2/SMAD1,8
GO:1904018,positive regulation of vasculature development,8/87,134/13083,0.05970149253731343,8.977869274318063,7.594742379421413,2.908255498032922e-6,8.481284638449497e-5,5.667004593474188e-5,RUNX1/ETS1/SERPINE1/DDAH1/FGF2/THBS1/TGM2/SMAD1,8
GO:0014855,striated muscle cell proliferation,6/87,61/13083,0.09836065573770492,14.791407574901074,8.833371844986821,3.0085683727630292e-6,8.67297641251687e-5,5.795088747052319e-5,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:0061448,connective tissue development,10/87,233/13083,0.04291845493562232,6.454047654284445,6.872854854445464,3.1903764152100096e-6,9.052093802025067e-5,6.04840650248632e-5,RUNX1/CCN2/CCN1/FGF2/SMAD7/SMAD3/RUNX2/CTNNB1/ARRDC3/SMAD1,10
GO:0060563,neuroepithelial cell differentiation,5/87,35/13083,0.14285714285714285,21.482758620689655,9.927555933087966,3.2122661418669497e-6,9.052093802025067e-5,6.04840650248632e-5,JAG1/SERPINE1/FGF2/SMAD2/CTNNB1,5
GO:0048565,digestive tract development,7/87,96/13083,0.07291666666666667,10.965158045977013,8.0178372145958825,3.325062856416477e-6,9.164019388892883e-5,6.123192674858335e-5,TGFB2/SMAD2/TP63/SMAD3/EGFR/CTNNB1/YAP1,7
GO:0072089,stem cell proliferation,7/87,96/13083,0.07291666666666667,10.965158045977013,8.0178372145958825,3.325062856416477e-6,9.164019388892883e-5,6.123192674858335e-5,RUNX1/NF2/FGF2/TP63/RUNX2/CTNNB1/YAP1,7
GO:0003170,heart valve development,6/87,63/13083,0.09523809523809523,14.32183908045977,8.672030833313864,3.6426534161197606e-6,9.823413728632645e-5,6.563785216143359e-5,CCN1/JAG1/TGFB2/SLIT2/SMAD2/SMAD6,6
GO:0055017,cardiac muscle tissue growth,6/87,63/13083,0.09523809523809523,14.32183908045977,8.672030833313864,3.6426534161197606e-6,9.823413728632645e-5,6.563785216143359e-5,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:0010810,regulation of cell-substrate adhesion,9/87,185/13083,0.04864864864864865,7.315750232991613,7.078503840664928,3.6952519184869104e-6,9.859246608048055e-5,6.587727944267818e-5,NF2/DAB2/CCN1/JAG1/SERPINE1/THBS1/DLC1/SMAD3/GSK3B,9
GO:0008543,fibroblast growth factor receptor signaling pathway,6/87,64/13083,0.09375,14.098060344827585,8.594092184342493,3.998198202272516e-6,1.0555243253999442e-4,7.052777327443596e-5,CCN2/SHCBP1/FGF2/THBS1/RUNX2/CTNNB1,6
GO:0032924,activin receptor signaling pathway,5/87,37/13083,0.13513513513513514,20.3215284249767,9.629317365112842,4.268408075262533e-6,1.1151216096623368e-4,7.450993043660035e-5,INHBA/SMAD7/SMAD2/SMAD3/SMAD6,5
GO:0055123,digestive system development,7/87,103/13083,0.06796116504854369,10.219953130231001,7.686025602900584,5.323897374892233e-6,1.3765293418793528e-4,9.197661010123096e-5,TGFB2/SMAD2/TP63/SMAD3/EGFR/CTNNB1/YAP1,7
GO:0001952,regulation of cell-matrix adhesion,7/87,104/13083,0.0673076923076923,10.121684350132625,7.641224165799063,5.677604905505256e-6,1.4476115898289413e-4,9.672616683487259e-5,NF2/JAG1/SERPINE1/THBS1/DLC1/SMAD3/GSK3B,7
GO:0072091,regulation of stem cell proliferation,6/87,68/13083,0.08823529411764706,13.268762677484789,8.298985068519006,5.714256275640558e-6,1.4476115898289413e-4,9.672616683487259e-5,NF2/FGF2/TP63/RUNX2/CTNNB1/YAP1,6
GO:0060419,heart growth,6/87,69/13083,0.08695652173913043,13.076461769115442,8.22906897195221,6.225344023680814e-6,1.561316281139148e-4,1.0432365984947216e-4,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:1905314,semi-lunar valve development,5/87,40/13083,0.125,18.79741379310345,9.223377708319514,6.343187855773811e-6,1.575120311116903e-4,1.0524601424066605e-4,JAG1/TGFB2/SLIT2/SMAD2/SMAD6,5
GO:0014706,striated muscle tissue development,11/87,311/13083,0.03536977491961415,5.318882359463355,6.306871195857044,6.436405417073772e-6,1.5825985084334335e-4,1.0574569064996331e-4,RUNX1/CDK1/CENPF/TGFB2/FGF2/SMAD7/SMAD3/CTNNB1/CREB1/YAP1/SMAD1,11
GO:0048638,regulation of developmental growth,10/87,255/13083,0.0392156862745098,5.897227856659905,6.461491437661914,7.105237868467626e-6,1.7300909295259035e-4,1.1560080415534448e-4,RUNX1/CDK1/LATS2/FGF2/SMAD7/GSK3B/WWC2/CREB1/YAP1/STK3,10
GO:0032330,regulation of chondrocyte differentiation,5/87,41/13083,0.12195121951219512,18.338940285954585,9.09775482187085,7.186555689106414e-6,1.7330655450268162e-4,1.1579956130624907e-4,CCN2/SMAD7/SMAD3/RUNX2/CTNNB1,5
GO:0008544,epidermis development,10/87,258/13083,0.03875968992248062,5.828655439722,6.409132200792844,7.875149645772011e-6,1.8810357439615432e-4,1.25686598857835e-4,CCN2/LATS2/INHBA/JAG1/TGFB2/FGF2/TP63/EGFR/CTNNB1/YAP1,10
GO:0043588,skin development,9/87,208/13083,0.04326923076923077,6.506797082228117,6.550115673946225,9.581195395042882e-6,2.266946985921467e-4,1.5147232441815558e-4,LATS2/INHBA/JAG1/TGFB2/TP63/EGFR/CTNNB1/ARRDC3/YAP1,9
GO:0019827,stem cell population maintenance,8/87,159/13083,0.050314465408805034,7.566254608544785,6.815687244406278,1.0335089433250207e-5,2.4224676914571513e-4,1.6186386992360382e-4,TET1/MYC/JAG1/SMC3/TP63/CTNNB1/SMARCA2/YAP1,8
GO:0060537,muscle tissue development,11/87,328/13083,0.03353658536585366,5.043208578637511,6.06756844101513,1.0645661298666631e-5,2.472159123801473e-4,1.6518414022882337e-4,RUNX1/CDK1/CENPF/TGFB2/FGF2/SMAD7/SMAD3/CTNNB1/CREB1/YAP1/SMAD1,11
GO:0090090,negative regulation of canonical Wnt signaling pathway,7/87,116/13083,0.0603448275862069,9.07461355529132,7.1469843821635815,1.1686282932080874e-5,2.6889172104274157e-4,1.796674304961154e-4,LATS2/DAB2/BICC1/GSK3B/CTNNB1/WWTR1/STK3,7
GO:0098727,maintenance of cell number,8/87,162/13083,0.04938271604938271,7.426138782460621,6.733663225536746,1.1849720180692291e-5,2.7017362011978426e-4,1.8052396677188637e-4,TET1/MYC/JAG1/SMC3/TP63/CTNNB1/SMARCA2/YAP1,8
GO:0048762,mesenchymal cell differentiation,9/87,214/13083,0.04205607476635514,6.324363519174992,6.425309215141865,1.2041621684123491e-5,2.7207556021424965e-4,1.8179480057965478e-4,DAB2/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1,9
GO:0016525,negative regulation of angiogenesis,6/87,78/13083,0.07692307692307693,11.56763925729443,7.6588215391520045,1.271655786431579e-5,2.8224006304162835e-4,1.8858649389837668e-4,GADD45A/SERPINE1/TGFB2/THBS1/AMOT/CTNNB1,6
GO:0072080,nephron tubule development,6/87,78/13083,0.07692307692307693,11.56763925729443,7.6588215391520045,1.271655786431579e-5,2.8224006304162835e-4,1.8858649389837668e-4,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:2000181,negative regulation of blood vessel morphogenesis,6/87,79/13083,0.0759493670886076,11.421213443910958,7.601253277342288,1.3688950662344932e-5,3.011569145715885e-4,2.0122631075210646e-4,GADD45A/SERPINE1/TGFB2/THBS1/AMOT/CTNNB1,6
GO:0030856,regulation of epithelial cell differentiation,7/87,120/13083,0.058333333333333334,8.77212643678161,6.997929565235082,1.4593510399481972e-5,3.1554883312137036e-4,2.108426686515662e-4,JAG1/SERPINE1/FGF2/TP63/CTNNB1/WWTR1/YAP1,7
GO:0043010,camera-type eye development,10/87,277/13083,0.036101083032490974,5.4288559691273495,6.095601117160187,1.4643989293746488e-5,3.1554883312137036e-4,2.108426686515662e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:1901343,negative regulation of vasculature development,6/87,80/13083,0.075,11.278448275862068,7.5447110960926365,1.4720579535566322e-5,3.1554883312137036e-4,2.108426686515662e-4,GADD45A/SERPINE1/TGFB2/THBS1/AMOT/CTNNB1,6
GO:0009880,embryonic pattern specification,5/87,48/13083,0.10416666666666667,15.664511494252874,8.32768997123734,1.5831354950759927e-5,3.3648337471615166e-4,2.2483066085289744e-4,SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,5
GO:0061326,renal tubule development,6/87,82/13083,0.07317073170731707,11.00336417157275,7.434580597591422,1.6972361466625887e-5,3.5770321477561116e-4,2.3900928310365685e-4,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:0010812,negative regulation of cell-substrate adhesion,5/87,49/13083,0.10204081632653061,15.344827586206897,8.230881738556105,1.7538604859051907e-5,3.653734065672183e-4,2.4413433360824792e-4,NF2/JAG1/SERPINE1/THBS1/DLC1,5
GO:0034504,protein localization to nucleus,10/87,283/13083,0.0353356890459364,5.313756549287194,6.002548972268396,1.76276643519272e-5,3.653734065672183e-4,2.4413433360824792e-4,NF2/NUAK2/CDK1/LATS2/MDFIC/SMAD3/GSK3B/WWTR1/YAP1/STK3,10
GO:0042063,gliogenesis,10/87,285/13083,0.03508771929824561,5.276467029643073,5.972117620599949,1.873213225099942e-5,3.850835056189061e-4,2.573041807039782e-4,NF2/CDK1/NDRG1/TGFB2/FGF2/PHGDH/ETV5/HEXB/EGFR/CTNNB1,10
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,7/87,125/13083,0.056,8.421241379310345,6.821100110142081,1.9045355448988e-5,3.883394428135114e-4,2.5947972507307565e-4,TET1/LATS2/THBS1/SMAD7/SMAD2/SMAD3/SMAD6,7
GO:0001701,in utero embryonic development,11/87,351/13083,0.03133903133903134,4.712741919638472,5.768884609588985,2.00427425329481e-5,4.0538063123091807e-4,2.708662658103003e-4,TET1/GINS1/LATS2/CCN1/SMAD2/SMAD3/AMOT/EGFR/CTNNB1/YAP1/STK3,11
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,7/87,127/13083,0.05511811023622047,8.288623404833016,6.753108842472276,2.1114751500215686e-5,4.236463741003275e-4,2.8307102642815467e-4,TET1/LATS2/THBS1/SMAD7/SMAD2/SMAD3/SMAD6,7
GO:0048738,cardiac muscle tissue development,8/87,177/13083,0.04519774011299435,6.796804987336841,6.352890071603709,2.2536017418804472e-5,4.4857406100287e-4,2.997271489618773e-4,RUNX1/CDK1/TGFB2/FGF2/SMAD7/CREB1/YAP1/SMAD1,8
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,6/87,87/13083,0.06896551724137931,10.370986920332937,7.175166016074647,2.3836060645743507e-5,4.707152763742104e-4,3.145214135766569e-4,DAB2/CCN1/INHBA/TGFB2/THBS1/SMAD2,6
GO:0045926,negative regulation of growth,8/87,180/13083,0.044444444444444446,6.6835249042145595,6.282037414295412,2.5435452361949328e-5,4.983758947169446e-4,3.330036197386787e-4,DAB2/INHBA/TGFB2/SLIT2/SMAD3/WWC2/SMARCA2/STK3,8
GO:0003206,cardiac chamber morphogenesis,6/87,89/13083,0.06741573033707865,10.137931034482758,7.0772297673478635,2.714003325495269e-5,5.276527395614058e-4,3.525657522797607e-4,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0001707,mesoderm formation,5/87,54/13083,0.09259259259259259,13.924010217113665,7.786288260194836,2.8338290803556347e-5,5.413699041261525e-4,3.6173125466668125e-4,NF2/INHBA/SMAD2/SMAD3/SMAD1,5
GO:0042475,odontogenesis of dentin-containing tooth,5/87,54/13083,0.09259259259259259,13.924010217113665,7.786288260194836,2.8338290803556347e-5,5.413699041261525e-4,3.6173125466668125e-4,NF2/SERPINE1/TP63/RUNX2/CTNNB1,5
GO:1901654,response to ketone,8/87,183/13083,0.04371584699453552,6.573958922178255,6.212784660215024,2.8641623240649013e-5,5.413699041261525e-4,3.6173125466668125e-4,INHBA/TGFB2/SLIT2/THBS1/SGK1/EGFR/CREB1/YAP1,8
GO:0003231,cardiac ventricle development,6/87,90/13083,0.06666666666666667,10.025287356321838,7.029418842269255,2.8924867285847065e-5,5.413699041261525e-4,3.6173125466668125e-4,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0003279,cardiac septum development,6/87,90/13083,0.06666666666666667,10.025287356321838,7.029418842269255,2.8924867285847065e-5,5.413699041261525e-4,3.6173125466668125e-4,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0044344,cellular response to fibroblast growth factor stimulus,6/87,91/13083,0.06593406593406594,9.915119363395226,6.982351369929104,3.0802910151120005e-5,5.71860107562889e-4,3.821041262654743e-4,CCN2/SHCBP1/FGF2/THBS1/RUNX2/CTNNB1,6
GO:0060390,regulation of SMAD protein signal transduction,5/87,55/13083,0.09090909090909091,13.670846394984327,7.704419881710147,3.100995798586639e-5,5.71860107562889e-4,3.821041262654743e-4,DAB2/INHBA/TGFB2/SMAD7/SMAD6,5
GO:0072182,regulation of nephron tubule epithelial cell differentiation,3/87,10/13083,0.3,45.11379310344827,11.417699764256724,3.295559434406014e-5,6.033038731014805e-4,4.0311414672104286e-4,CTNNB1/WWTR1/YAP1,3
GO:0048332,mesoderm morphogenesis,5/87,56/13083,0.08928571428571429,13.426724137931034,7.624657006169379,3.3873032967384606e-5,6.156055556681202e-4,4.1133385571377794e-4,NF2/INHBA/SMAD2/SMAD3/SMAD1,5
GO:0002067,glandular epithelial cell differentiation,5/87,57/13083,0.08771929824561403,13.191167574107682,7.546907711819443,3.693693621508053e-5,6.634130543104847e-4,4.432777564267151e-4,FGF2/TP63/GSK3B/CTNNB1/YAP1,5
GO:0072009,nephron epithelium development,6/87,94/13083,0.06382978723404255,9.598679383712398,6.845413257574076,3.703262663615146e-5,6.634130543104847e-4,4.432777564267151e-4,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,4/87,29/13083,0.13793103448275862,20.741973840665874,8.707823430993994,3.8159852993657544e-5,6.787582362276107e-4,4.535310635752356e-4,FGF2/THBS1/RUNX2/CTNNB1,4
GO:0030178,negative regulation of Wnt signaling pathway,7/87,140/13083,0.05,7.51896551724138,6.344787385536899,3.958559116233306e-5,6.942703680778415e-4,4.6389592293289827e-4,LATS2/DAB2/BICC1/GSK3B/CTNNB1/WWTR1/STK3,7
GO:0051017,actin filament bundle assembly,7/87,140/13083,0.05,7.51896551724138,6.344787385536899,3.958559116233306e-5,6.942703680778415e-4,4.6389592293289827e-4,NF2/CCN2/MARCKS/DLC1/ITGB5/SMAD3/AMOT,7
GO:0001654,eye development,10/87,312/13083,0.03205128205128205,4.819849690539345,5.587312546588739,4.059351478167857e-5,7.070037157809018e-4,4.724040609095927e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0002062,chondrocyte differentiation,6/87,96/13083,0.0625,9.398706896551724,6.7574908896543615,4.17199563073712e-5,7.145491181190363e-4,4.7744572989402576e-4,RUNX1/CCN2/SMAD7/SMAD3/RUNX2/CTNNB1,6
GO:0071774,response to fibroblast growth factor,6/87,96/13083,0.0625,9.398706896551724,6.7574908896543615,4.17199563073712e-5,7.145491181190363e-4,4.7744572989402576e-4,CCN2/SHCBP1/FGF2/THBS1/RUNX2/CTNNB1,6
GO:0097191,extrinsic apoptotic signaling pathway,8/87,193/13083,0.04145077720207254,6.23333928890477,5.992705492613929,4.188146744956074e-5,7.145491181190363e-4,4.7744572989402576e-4,INHBA/SERPINE1/TGFB2/THBS1/SMAD3/GSK3B/YAP1/STK3,8
GO:0061572,actin filament bundle organization,7/87,142/13083,0.04929577464788732,7.41306459446333,6.286627315948335,4.334700072204165e-5,7.310418975097401e-4,4.884658359924057e-4,NF2/CCN2/MARCKS/DLC1/ITGB5/SMAD3/AMOT,7
GO:0045165,cell fate commitment,8/87,194/13083,0.041237113402061855,6.201208674013508,5.971554202265293,4.344847747442472e-5,7.310418975097401e-4,4.884658359924057e-4,LATS2/JAG1/ETS2/FGF2/SMAD2/RUNX2/CTNNB1/SMAD1,8
GO:0060043,regulation of cardiac muscle cell proliferation,4/87,30/13083,0.13333333333333333,20.050574712643677,8.54683633426519,4.3807915645425105e-5,7.310418975097401e-4,4.884658359924057e-4,RUNX1/CDK1/FGF2/YAP1,4
GO:0150063,visual system development,10/87,315/13083,0.031746031746031744,4.773946360153256,5.547296897461876,4.4014085535873505e-5,7.310418975097401e-4,4.884658359924057e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0009950,dorsal/ventral axis specification,3/87,11/13083,0.2727272727272727,41.01253918495298,10.862087146645965,4.509608865120084e-5,7.383114786534348e-4,4.933232074272929e-4,SMAD2/CTNNB1/SMAD6,3
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,3/87,11/13083,0.2727272727272727,41.01253918495298,10.862087146645965,4.509608865120084e-5,7.383114786534348e-4,4.933232074272929e-4,CTNNB1/WWTR1/YAP1,3
GO:0061138,morphogenesis of a branching epithelium,7/87,143/13083,0.04895104895104895,7.361224981914638,6.2579700998112555,4.5334915355912666e-5,7.383114786534348e-4,4.933232074272929e-4,MYC/FGF2/SLIT2/TGM2/TP63/CTNNB1/YAP1,7
GO:0048880,sensory system development,10/87,317/13083,0.031545741324921134,4.743826824757968,5.520899101315869,4.642897955196818e-5,7.487517580641726e-4,5.00299168487435e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0030038,contractile actin filament bundle assembly,6/87,98/13083,0.061224489795918366,9.206896551724139,6.672104925422891,4.6871621218530744e-5,7.487517580641726e-4,5.00299168487435e-4,NF2/CCN2/DLC1/ITGB5/SMAD3/AMOT,6
GO:0043149,stress fiber assembly,6/87,98/13083,0.061224489795918366,9.206896551724139,6.672104925422891,4.6871621218530744e-5,7.487517580641726e-4,5.00299168487435e-4,NF2/CCN2/DLC1/ITGB5/SMAD3/AMOT,6
GO:0003281,ventricular septum development,5/87,60/13083,0.08333333333333333,12.531609195402298,7.324902833859372,4.743150750855592e-5,7.529001318446724e-4,5.030710190114657e-4,CCN1/TGFB2/SLIT2/SMAD7/SMAD6,5
GO:2001233,regulation of apoptotic signaling pathway,10/87,322/13083,0.031055900621118012,4.670164917541229,5.455857372607343,5.2967423049267326e-5,8.354861447016506e-4,5.582531446172365e-4,MYC/INHBA/SERPINE1/FGF2/THBS1/TP63/GSK3B/CTNNB1/YAP1/STK3,10
GO:0048863,stem cell differentiation,8/87,200/13083,0.04,6.015172413793104,5.847688225506046,5.391558300055704e-5,8.448079276083417e-4,5.644817513441115e-4,JAG1/TGFB2/FGF2/TP63/RUNX2/GSK3B/CTNNB1/YAP1,8
GO:0060562,epithelial tube morphogenesis,9/87,259/13083,0.03474903474903475,5.2255358807082946,5.619682357751402,5.423208785683534e-5,8.448079276083417e-4,5.644817513441115e-4,MYC/TGFB2/FGF2/SLIT2/DLC1/SMAD3/CTNNB1/YAP1/STK3,9
GO:0003180,aortic valve morphogenesis,4/87,32/13083,0.125,18.79741379310345,8.24711099611411,5.690356664496314e-5,8.809515132442442e-4,5.886320864118345e-4,JAG1/SLIT2/SMAD2/SMAD6,4
GO:0045927,positive regulation of growth,8/87,202/13083,0.039603960396039604,5.955616251280301,5.807515939660979,5.784035886355357e-5,8.899608590784806e-4,5.946519296788974e-4,CDK1/TGFB2/FGF2/SMAD7/TEAD1/EGFR/CREB1/YAP1,8
GO:0007254,JNK cascade,7/87,149/13083,0.04697986577181208,7.064799814857673,6.091651135541876,5.889696227043375e-5,9.006925693551698e-4,6.01822618321762e-4,CCN2/GADD45B/GADD45A/MDFIC/TAOK1/SMAD3/STK3,7
GO:0072160,nephron tubule epithelial cell differentiation,3/87,12/13083,0.25,37.5948275862069,10.37642540728398,5.983911990266756e-5,9.095546225205469e-4,6.077440439237431e-4,CTNNB1/WWTR1/YAP1,3
GO:0040017,positive regulation of locomotion,12/87,473/13083,0.02536997885835095,3.8151199241816722,5.1022504774363,6.54601229965771e-5,9.889999305747914e-4,6.608276208658893e-4,DAB2/CCN1/ETS1/SERPINE1/TGFB2/FGF2/SLIT2/THBS1/SMAD3/AMOT/FAT1/EGFR,12
GO:0002088,lens development in camera-type eye,5/87,65/13083,0.07692307692307693,11.56763925729443,6.9880237386934745,6.988936698346126e-5,0.0010495960023624003,7.013165599601028e-4,NF2/FGF2/SMAD3/FAT1/CTNNB1,5
GO:0048545,response to steroid hormone,9/87,268/13083,0.033582089552238806,5.050051466803912,5.481008571612484,7.059295472197439e-5,0.0010538519669209033,7.041603002342306e-4,DAB2/INHBA/TGFB2/SLIT2/THBS1/SGK1/TP63/EGFR/YAP1,9
GO:0097305,response to alcohol,8/87,208/13083,0.038461538461538464,5.783819628647215,5.690162804810557,7.107100918285489e-5,0.0010547105978142015,7.047340181819057e-4,CDK1/INHBA/FGF2/SLIT2/SGK1/SMAD2/CTNNB1/CREB1,8
GO:0016202,regulation of striated muscle tissue development,4/87,34/13083,0.11764705882352941,17.691683569979716,7.973386810013764,7.264596644593295e-5,0.001071741669684705,7.161137992688869e-4,CENPF/SMAD3/CTNNB1/CREB1,4
GO:2000036,regulation of stem cell population maintenance,5/87,66/13083,0.07575757575757576,11.392371995820271,6.92505212461658,7.522504406024751e-5,0.0011033006462169636,7.37200801132127e-4,TET1/MYC/TP63/SMARCA2/YAP1,5
GO:0030214,hyaluronan catabolic process,3/87,13/13083,0.23076923076923078,34.70291777188329,9.94702548248802,7.74170631537852e-5,0.00112884880459124,7.542715088177847e-4,FGF2/HMMR/HEXB,3
GO:0043534,blood vessel endothelial cell migration,6/87,108/13083,0.05555555555555555,8.354406130268199,6.279103634021158,8.081195275885954e-5,0.0011563035321102224,7.726161433389884e-4,ETS1/GADD45A/FGF2/SLIT2/THBS1/AMOT,6
GO:0045598,regulation of fat cell differentiation,6/87,108/13083,0.05555555555555555,8.354406130268199,6.279103634021158,8.081195275885954e-5,0.0011563035321102224,7.726161433389884e-4,JAG1/SMAD3/CREB1/WWTR1/YAP1/STK3,6
GO:0035850,epithelial cell differentiation involved in kidney development,4/87,35/13083,0.11428571428571428,17.186206896551724,7.84510901513719,8.160515358194153e-5,0.0011563035321102224,7.726161433389884e-4,JAG1/CTNNB1/WWTR1/YAP1,4
GO:0048634,regulation of muscle organ development,4/87,35/13083,0.11428571428571428,17.186206896551724,7.84510901513719,8.160515358194153e-5,0.0011563035321102224,7.726161433389884e-4,CENPF/SMAD3/CTNNB1/CREB1,4
GO:1901861,regulation of muscle tissue development,4/87,35/13083,0.11428571428571428,17.186206896551724,7.84510901513719,8.160515358194153e-5,0.0011563035321102224,7.726161433389884e-4,CENPF/SMAD3/CTNNB1/CREB1,4
GO:0001763,morphogenesis of a branching structure,7/87,158/13083,0.04430379746835443,6.662374508948058,5.8587329835909525,8.532460041496784e-5,0.0011954977533002197,7.988048448140475e-4,MYC/FGF2/SLIT2/TGM2/TP63/CTNNB1/YAP1,7
GO:0050679,positive regulation of epithelial cell proliferation,7/87,158/13083,0.04430379746835443,6.662374508948058,5.8587329835909525,8.532460041496784e-5,0.0011954977533002197,7.988048448140475e-4,MYC/FGF2/TP63/RUNX2/EGFR/CTNNB1/YAP1,7
GO:0030324,lung development,7/87,159/13083,0.0440251572327044,6.6204727824766865,5.833977957724778,8.877806473649429e-5,0.0012369743686618205,8.265185909970696e-4,CCN2/FGF2/SMAD2/EGFR/CTNNB1/CREB1/YAP1,7
GO:0030857,negative regulation of epithelial cell differentiation,4/87,36/13083,0.1111111111111111,16.708812260536398,7.722023446469427,9.134193111164493e-5,0.0012656660951823509,8.456897605684136e-4,JAG1/TP63/CTNNB1/YAP1,4
GO:0043116,negative regulation of vascular permeability,3/87,14/13083,0.21428571428571427,32.224137931034484,9.56368235081986,9.805748343456179e-5,0.0013438697729720272,8.979437079541118e-4,DDAH1/SLIT2/AMOT,3
GO:0072202,cell differentiation involved in metanephros development,3/87,14/13083,0.21428571428571427,32.224137931034484,9.56368235081986,9.805748343456179e-5,0.0013438697729720272,8.979437079541118e-4,CTNNB1/WWTR1/YAP1,3
GO:0003176,aortic valve development,4/87,37/13083,0.10810810810810811,16.257222739981362,7.603779403061081,1.0189629754029724e-4,0.0013813833201679214,9.230094206779698e-4,JAG1/SLIT2/SMAD2/SMAD6,4
GO:2000648,positive regulation of stem cell proliferation,4/87,37/13083,0.10810810810810811,16.257222739981362,7.603779403061081,1.0189629754029724e-4,0.0013813833201679214,9.230094206779698e-4,FGF2/TP63/RUNX2/CTNNB1,4
GO:0030323,respiratory tube development,7/87,163/13083,0.04294478527607362,6.458007192722657,5.737048170493594,1.0375236533085498e-4,0.001398449920545707,9.344129411184274e-4,CCN2/FGF2/SMAD2/EGFR/CTNNB1/CREB1/YAP1,7
GO:0003013,circulatory system process,11/87,421/13083,0.026128266033254157,3.929150626586944,4.9983129672456,1.042703888126185e-4,0.001398449920545707,9.344129411184274e-4,MYOF/TGFB2/DDAH1/SLIT2/SGK1/SMAD7/SMAD3/AMOT/EGFR/WWTR1/YAP1,11
GO:0010720,positive regulation of cell development,10/87,350/13083,0.02857142857142857,4.296551724137931,5.114702695765288,1.0602807049822382e-4,0.0014144595787741773,9.4511023646793e-4,RUNX1/FGF2/SLIT2/ETV5/TGM2/SMAD7/EGFR/CTNNB1/CREB1/SMARCA2,10
GO:0007492,endoderm development,5/87,71/13083,0.07042253521126761,10.59009227780476,6.629362701084993,1.0677551834269532e-4,0.001416894179912592,9.467369824648896e-4,INHBA/ITGB5/SMAD2/SMAD3/CTNNB1,5
GO:0045637,regulation of myeloid cell differentiation,7/87,165/13083,0.04242424242424243,6.379728317659353,5.689793741417609,1.1197619325186013e-4,0.0014780857509245535,9.8762382081419e-4,RUNX1/ETS1/MYC/INHBA/JAG1/CTNNB1/CREB1,7
GO:1903670,regulation of sprouting angiogenesis,4/87,38/13083,0.10526315789473684,15.829401088929218,7.49005860179315,1.1330885880437879e-4,0.001483331380544123,9.911288331344932e-4,FGF2/THBS1/TGM2/SMAD1,4
GO:0048568,embryonic organ development,10/87,353/13083,0.028328611898016998,4.260037120250073,5.080278763440617,1.1374570184352143e-4,0.001483331380544123,9.911288331344932e-4,CCN1/TGFB2/TEAD1/SMAD2/SMAD3/RUNX2/EGFR/CTNNB1/YAP1/STK3,10
GO:2000736,regulation of stem cell differentiation,5/87,72/13083,0.06944444444444445,10.44300766283525,6.573748720038322,1.1414790926834758e-4,0.001483331380544123,9.911288331344932e-4,JAG1/TGFB2/FGF2/GSK3B/YAP1,5
GO:0035148,tube formation,6/87,116/13083,0.05172413793103448,7.778240190249703,5.999541209810919,1.2011272828395765e-4,0.0015527975388462156,0.0010375445655347833,TGFB2/FGF2/DLC1/TGM2/CTNNB1/STK3,6
GO:0001942,hair follicle development,5/87,73/13083,0.0684931506849315,10.299952763344354,6.519216017214584,1.2190477364554673e-4,0.0015678829348873395,0.0010476242895746848,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0045216,cell-cell junction organization,7/87,168/13083,0.041666666666666664,6.265804597701149,5.62035855176169,1.2530030646893794e-4,0.0015952020815781045,0.0010658783320206253,NF2/TGFB2/SMAD7/SMAD3/MPDZ/AMOT/CTNNB1,7
GO:0045747,positive regulation of Notch signaling pathway,4/87,39/13083,0.10256410256410256,15.423519009725906,7.380571418704859,1.2562080213458912e-4,0.0015952020815781045,0.0010658783320206253,JAG1/TGFB2/TP63/YAP1,4
GO:0046328,regulation of JNK cascade,6/87,117/13083,0.05128205128205128,7.711759504862953,5.966479545666976,1.2593700644037667e-4,0.0015952020815781045,0.0010658783320206253,CCN2/GADD45B/GADD45A/MDFIC/TAOK1/STK3,6
GO:0070371,ERK1 and ERK2 cascade,8/87,228/13083,0.03508771929824561,5.276467029643073,5.329768656332279,1.3465092825051318e-4,0.0016970076786547088,0.001133902553688532,CDK1/CCN2/DAB2/CCN1/MYC/INHBA/FGF2/EGFR,8
GO:0002762,negative regulation of myeloid leukocyte differentiation,4/87,40/13083,0.1,15.03793103448276,7.275053649904335,1.38873870387791e-4,0.0017275859349397376,0.0011543342602300267,RUNX1/MYC/INHBA/CTNNB1,4
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,4/87,40/13083,0.1,15.03793103448276,7.275053649904335,1.38873870387791e-4,0.0017275859349397376,0.0011543342602300267,SERPINE1/THBS1/GSK3B/STK3,4
GO:0071407,cellular response to organic cyclic compound,11/87,435/13083,0.02528735632183908,3.802695204122077,4.8640879357613285,1.3914368375511442e-4,0.0017275859349397376,0.0011543342602300267,CDK1/DAB2/INHBA/TGM2/SGK1/TP63/GSK3B/EGFR/CTNNB1/CREB1/SMAD1,11
GO:0009611,response to wounding,11/87,436/13083,0.02522935779816514,3.7939734261309717,4.854713485414459,1.4197621444525486e-4,0.0017540706691068927,0.001172030766900937,CDK1/CCN2/CCN1/MYOF/SERPINE1/TGFB2/FGF2/THBS1/ITGB5/SMAD3/YAP1,11
GO:0022404,molting cycle process,5/87,76/13083,0.06578947368421052,9.893375680580762,6.361751661188099,1.4761808614317622e-4,0.0017929480729261442,0.0011980077780988925,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0022405,hair cycle process,5/87,76/13083,0.06578947368421052,9.893375680580762,6.361751661188099,1.4761808614317622e-4,0.0017929480729261442,0.0011980077780988925,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:1902106,negative regulation of leukocyte differentiation,5/87,76/13083,0.06578947368421052,9.893375680580762,6.361751661188099,1.4761808614317622e-4,0.0017929480729261442,0.0011980077780988925,RUNX1/MYC/INHBA/SMAD7/CTNNB1,5
GO:0032332,positive regulation of chondrocyte differentiation,3/87,16/13083,0.1875,28.19612068965517,8.905757246640489,1.49412339410512e-4,0.0017929480729261442,0.0011980077780988925,SMAD7/SMAD3/RUNX2,3
GO:0048339,paraxial mesoderm development,3/87,16/13083,0.1875,28.19612068965517,8.905757246640489,1.49412339410512e-4,0.0017929480729261442,0.0011980077780988925,SMAD2/SMAD3/YAP1,3
GO:0071895,odontoblast differentiation,3/87,16/13083,0.1875,28.19612068965517,8.905757246640489,1.49412339410512e-4,0.0017929480729261442,0.0011980077780988925,SERPINE1/SMAD2/CTNNB1,3
GO:0051338,regulation of transferase activity,11/87,439/13083,0.025056947608200455,3.768046500667662,4.826754892965297,1.5077099951652136e-4,0.0018006365085115978,0.0012031450186982555,LATS2/CCN1/GADD45A/TGFB2/FGF2/THBS1/SMAD7/GSK3B/EGFR/ARRDC3/WWTR1,11
GO:0044843,cell cycle G1/S phase transition,8/87,233/13083,0.034334763948497854,5.163238123427557,5.246256204661909,1.5634150053174965e-4,0.0018579292691371777,0.001241426759198517,CDK1/LATS2/MYC/CCNA1/INHBA/TP63/EGFR/SMARCA2,8
GO:0046330,positive regulation of JNK cascade,5/87,77/13083,0.06493506493506493,9.764890282131661,6.311198199262054,1.5704984252674708e-4,0.0018579292691371777,0.001241426759198517,CCN2/GADD45B/GADD45A/TAOK1/STK3,5
GO:0045785,positive regulation of cell adhesion,10/87,369/13083,0.02710027100271003,4.075320063545463,4.902913694937957,1.6344390437069103e-4,0.001924494423294334,0.0012859041055504825,RUNX1/DAB2/CCN1/ETS1/TGFB2/TGM2/SMAD7/SMAD3/GSK3B/SMARCA2,10
GO:0045668,negative regulation of osteoblast differentiation,4/87,42/13083,0.09523809523809523,14.32183908045977,7.074980194714734,1.6837298044622312e-4,0.0019732683876594746,0.0013184937770309255,CRIM1/SMAD3/GSK3B/SMAD6,4
GO:0030335,positive regulation of cell migration,11/87,446/13083,0.02466367713004484,3.7089067573836396,4.762459994269748,1.7311683810885254e-4,0.002011863342981107,0.0013442820624636627,DAB2/CCN1/ETS1/SERPINE1/TGFB2/FGF2/THBS1/SMAD3/AMOT/FAT1/EGFR,11
GO:0072006,nephron development,6/87,124/13083,0.04838709677419355,7.276418242491657,5.745513124361275,1.7327052714669823e-4,0.002011863342981107,0.0013442820624636627,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:0045639,positive regulation of myeloid cell differentiation,5/87,79/13083,0.06329113924050633,9.517677869925796,6.2128107415312,1.7729019294736303e-4,0.002049049787612841,0.0013691292125743485,RUNX1/ETS1/INHBA/JAG1/CREB1,5
GO:0010755,regulation of plasminogen activation,3/87,17/13083,0.17647058823529413,26.537525354969578,8.6203280217325,1.8055841422984881e-4,0.002067764853371967,0.0013816342006917534,RUNX1/SERPINE1/THBS1,3
GO:0060571,morphogenesis of an epithelial fold,3/87,17/13083,0.17647058823529413,26.537525354969578,8.6203280217325,1.8055841422984881e-4,0.002067764853371967,0.0013816342006917534,TP63/EGFR/CTNNB1,3
GO:0061005,cell differentiation involved in kidney development,4/87,43/13083,0.09302325581395349,13.988773055332798,6.979999767788762,1.8470506152532467e-4,0.0021056377013887015,0.001406939990183334,JAG1/CTNNB1/WWTR1/YAP1,4
GO:0002064,epithelial cell development,7/87,180/13083,0.03888888888888889,5.84808429118774,5.35861941632648,1.9211288933264372e-4,0.002180177042743305,0.0014567455099669861,AMOTL2/JAG1/TP63/GSK3B/FAT1/FRMD6/YAP1,7
GO:0048511,rhythmic process,8/87,241/13083,0.03319502074688797,4.9918443267992565,5.117497418756523,1.9699606013527402e-4,0.002220374732030296,0.0014836047063679302,CDK1/INHBA/TGFB2/SLIT2/USP9X/GSK3B/EGFR/CREB1,8
GO:0003205,cardiac chamber development,6/87,127/13083,0.047244094488188976,7.104534346999729,5.6560179595181115,1.9742566397239076e-4,0.002220374732030296,0.0014836047063679302,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0060541,respiratory system development,7/87,181/13083,0.03867403314917127,5.815774433225376,5.337879342560222,1.98776729168486e-4,0.0022255894497971557,0.0014870890640800267,CCN2/FGF2/SMAD2/EGFR/CTNNB1/CREB1/YAP1,7
GO:0072132,mesenchyme morphogenesis,4/87,44/13083,0.09090909090909091,13.670846394984327,6.888135298827898,2.0215029792352703e-4,0.0022533019875209145,0.0015056059616105496,MYC/TGFB2/SMAD2/SMAD3,4
GO:0051492,regulation of stress fiber assembly,5/87,82/13083,0.06097560975609756,9.169470142977293,6.071615826021883,2.1131476352957877e-4,0.002345032862531786,0.0015668984794554696,NF2/CCN2/DLC1/SMAD3/AMOT,5
GO:2001236,regulation of extrinsic apoptotic signaling pathway,6/87,129/13083,0.046511627906976744,6.994386527666399,5.597956246137882,2.149535107907743e-4,0.002361576235982215,0.0015779523913723183,INHBA/SERPINE1/THBS1/GSK3B/YAP1/STK3,6
GO:0007398,ectoderm development,3/87,18/13083,0.16666666666666666,25.063218390804597,8.358476109837708,2.156303660446281e-4,0.002361576235982215,0.0015779523913723183,NF2/ETS2/CTNNB1,3
GO:0031053,primary miRNA processing,3/87,18/13083,0.16666666666666666,25.063218390804597,8.358476109837708,2.156303660446281e-4,0.002361576235982215,0.0015779523913723183,SMAD2/SMAD3/SMAD1,3
GO:0010596,negative regulation of endothelial cell migration,4/87,45/13083,0.08888888888888889,13.367049808429119,6.799214240348069,2.207528415910327e-4,0.0023967451372740693,0.0016014514641737253,GADD45A/FGF2/SLIT2/THBS1,4
GO:0055021,regulation of cardiac muscle tissue growth,4/87,45/13083,0.08888888888888889,13.367049808429119,6.799214240348069,2.207528415910327e-4,0.0023967451372740693,0.0016014514641737253,RUNX1/CDK1/FGF2/YAP1,4
GO:1903707,negative regulation of hemopoiesis,5/87,83/13083,0.060240963855421686,9.058994599085999,6.026152003742588,2.2369403559864735e-4,0.0024182096606957222,0.0016157935783713546,RUNX1/MYC/INHBA/SMAD7/CTNNB1,5
GO:1903706,regulation of hemopoiesis,9/87,313/13083,0.02875399361022364,4.324005728765011,4.870015361477672,2.2834983853813227e-4,0.0024579459015177498,0.0016423444452347256,RUNX1/ETS1/MYC/INHBA/JAG1/SMAD7/CTNNB1/CREB1/SMARCA2,9
GO:2000147,positive regulation of cell motility,11/87,461/13083,0.02386117136659436,3.588226494128207,4.628928799263852,2.3064543923850638e-4,0.0024720459897870683,0.0016517658086716244,DAB2/CCN1/ETS1/SERPINE1/TGFB2/FGF2/THBS1/SMAD3/AMOT/FAT1/EGFR,11
GO:0043535,regulation of blood vessel endothelial cell migration,5/87,84/13083,0.05952380952380952,8.951149425287356,5.981449407458675,2.3661806796166753e-4,0.002525268572118563,0.001687327947121947,ETS1/GADD45A/FGF2/THBS1/AMOT,5
GO:0051496,positive regulation of stress fiber assembly,4/87,46/13083,0.08695652173913043,13.076461769115442,6.713077195549318,2.405572556016615e-4,0.002545643869404924,0.0017009422647916725,NF2/CCN2/SMAD3/AMOT,4
GO:1902459,positive regulation of stem cell population maintenance,4/87,46/13083,0.08695652173913043,13.076461769115442,6.713077195549318,2.405572556016615e-4,0.002545643869404924,0.0017009422647916725,TET1/TP63/SMARCA2/YAP1,4
GO:0014912,negative regulation of smooth muscle cell migration,3/87,19/13083,0.15789473684210525,23.744101633393825,8.117071085682078,2.548326341135999e-4,0.0026630010264871184,0.0017793576908282935,IGFBP3/SERPINE1/SLIT2,3
GO:0031639,plasminogen activation,3/87,19/13083,0.15789473684210525,23.744101633393825,8.117071085682078,2.548326341135999e-4,0.0026630010264871184,0.0017793576908282935,RUNX1/SERPINE1/THBS1,3
GO:1903672,positive regulation of sprouting angiogenesis,3/87,19/13083,0.15789473684210525,23.744101633393825,8.117071085682078,2.548326341135999e-4,0.0026630010264871184,0.0017793576908282935,FGF2/TGM2/SMAD1,3
GO:0030514,negative regulation of BMP signaling pathway,4/87,47/13083,0.0851063829787234,12.798239178283199,6.629576655061402,2.616084915977962e-4,0.0027224651324783107,0.0018190902757095064,CRIM1/SMAD7/UBE2D1/SMAD6,4
GO:0042303,molting cycle,5/87,88/13083,0.056818181818181816,8.544278996865204,5.809821405061955,2.940815522170064e-4,0.0030133462119430227,0.002013450503405226,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0042633,hair cycle,5/87,88/13083,0.056818181818181816,8.544278996865204,5.809821405061955,2.940815522170064e-4,0.0030133462119430227,0.002013450503405226,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0043542,endothelial cell migration,7/87,193/13083,0.03626943005181347,5.454171877791674,5.10047959888243,2.943659577057578e-4,0.0030133462119430227,0.002013450503405226,ETS1/GADD45A/FSTL1/FGF2/SLIT2/THBS1/AMOT,7
GO:0045444,fat cell differentiation,7/87,193/13083,0.03626943005181347,5.454171877791674,5.10047959888243,2.943659577057578e-4,0.0030133462119430227,0.002013450503405226,JAG1/SMAD3/CREB1/WWTR1/YAP1/SMAD6/STK3,7
GO:0060045,positive regulation of cardiac muscle cell proliferation,3/87,20/13083,0.15,22.556896551724137,7.8935364616761,2.9836521287143297e-4,0.003041869731225829,0.0020325092806646183,CDK1/FGF2/YAP1,3
GO:0045599,negative regulation of fat cell differentiation,4/87,49/13083,0.08163265306122448,12.275862068965518,6.469947905066938,3.076330465719574e-4,0.003109628353164066,0.002077784075479389,JAG1/SMAD3/WWTR1/YAP1,4
GO:0060420,regulation of heart growth,4/87,49/13083,0.08163265306122448,12.275862068965518,6.469947905066938,3.076330465719574e-4,0.003109628353164066,0.002077784075479389,RUNX1/CDK1/FGF2/YAP1,4
GO:0030308,negative regulation of cell growth,6/87,138/13083,0.043478260869565216,6.538230884557721,5.351202925505367,3.096013323540744e-4,0.003109628353164066,0.002077784075479389,DAB2/INHBA/TGFB2/SLIT2/SMAD3/SMARCA2,6
GO:0002761,regulation of myeloid leukocyte differentiation,5/87,89/13083,0.056179775280898875,8.448275862068966,5.7686099235741075,3.0997092834570035e-4,0.003109628353164066,0.002077784075479389,RUNX1/MYC/INHBA/CTNNB1/CREB1,5
GO:0042060,wound healing,9/87,327/13083,0.027522935779816515,4.138880101233787,4.703088978119096,3.155161123515068e-4,0.003152647050906689,0.002106528206599282,CCN1/MYOF/SERPINE1/TGFB2/FGF2/THBS1/ITGB5/SMAD3/YAP1,9
GO:0007015,actin filament organization,10/87,401/13083,0.02493765586034913,3.75010748989595,4.576356281958033,3.1899429240036376e-4,0.0031747527196036205,0.0021212987197217173,NF2/CCN2/MARCKS/SLIT2/DLC1/ITGB5/SMAD3/AMOT/FAT1/ENAH,10
GO:0001706,endoderm formation,4/87,50/13083,0.08,12.030344827586209,6.393574665968105,3.3269801454617755e-4,0.003285065434967769,0.002195007207449294,INHBA/ITGB5/SMAD2/CTNNB1,4
GO:0061045,negative regulation of wound healing,4/87,50/13083,0.08,12.030344827586209,6.393574665968105,3.3269801454617755e-4,0.003285065434967769,0.002195007207449294,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0032231,regulation of actin filament bundle assembly,5/87,91/13083,0.054945054945054944,8.26259946949602,5.688092249588184,3.4369491815622473e-4,0.003366346849852506,0.0022493176298854986,NF2/CCN2/DLC1/SMAD3/AMOT,5
GO:0110020,regulation of actomyosin structure organization,5/87,91/13083,0.054945054945054944,8.26259946949602,5.688092249588184,3.4369491815622473e-4,0.003366346849852506,0.0022493176298854986,NF2/CCN2/DLC1/SMAD3/AMOT,5
GO:0030900,forebrain development,9/87,331/13083,0.027190332326283987,4.088863423273257,4.657098228477803,3.4495659506064355e-4,0.003366346849852506,0.0022493176298854986,NF2/INHBA/FGF2/SLIT2/DLC1/GSK3B/EGFR/CTNNB1/CREB1,9
GO:0031069,hair follicle morphogenesis,3/87,21/13083,0.14285714285714285,21.482758620689655,7.685729619402321,3.464237105534291e-4,0.003367560721193799,0.0022501287115506284,TGFB2/TP63/CTNNB1,3
GO:0043536,positive regulation of blood vessel endothelial cell migration,4/87,51/13083,0.0784313725490196,11.79445571331981,6.3193462026052,3.591930602865445e-4,0.003478209247871249,0.002324061580882661,ETS1/FGF2/THBS1/AMOT,4
GO:0003171,atrioventricular valve development,3/87,22/13083,0.13636363636363635,20.50626959247649,7.491852101579418,3.991994071955809e-4,0.0037638801249869056,0.0025149404679674107,CCN1/TGFB2/SMAD6,3
GO:0003181,atrioventricular valve morphogenesis,3/87,22/13083,0.13636363636363635,20.50626959247649,7.491852101579418,3.991994071955809e-4,0.0037638801249869056,0.0025149404679674107,CCN1/TGFB2/SMAD6,3
GO:0006027,glycosaminoglycan catabolic process,3/87,22/13083,0.13636363636363635,20.50626959247649,7.491852101579418,3.991994071955809e-4,0.0037638801249869056,0.0025149404679674107,FGF2/HMMR/HEXB,3
GO:0030859,polarized epithelial cell differentiation,3/87,22/13083,0.13636363636363635,20.50626959247649,7.491852101579418,3.991994071955809e-4,0.0037638801249869056,0.0025149404679674107,TP63/FAT1/YAP1,3
GO:0033688,regulation of osteoblast proliferation,3/87,22/13083,0.13636363636363635,20.50626959247649,7.491852101579418,3.991994071955809e-4,0.0037638801249869056,0.0025149404679674107,NF2/CCN1/SMAD3,3
GO:0060795,cell fate commitment involved in formation of primary germ layer,3/87,22/13083,0.13636363636363635,20.50626959247649,7.491852101579418,3.991994071955809e-4,0.0037638801249869056,0.0025149404679674107,ETS2/CTNNB1/SMAD1,3
GO:0120255,olefinic compound biosynthetic process,3/87,22/13083,0.13636363636363635,20.50626959247649,7.491852101579418,3.991994071955809e-4,0.0037638801249869056,0.0025149404679674107,DAB2/INHBA/CREB1,3
GO:0010721,negative regulation of cell development,7/87,204/13083,0.03431372549019608,5.160074374577418,4.899671398252297,4.116207220222097e-4,0.0038664598158490715,0.0025834819217794513,RUNX1/NF2/MYC/INHBA/SMAD7/GSK3B/CTNNB1,7
GO:0009913,epidermal cell differentiation,6/87,146/13083,0.0410958904109589,6.179971658006613,5.149663717226406,4.187379146515193e-4,0.003918636902783621,0.002618345483602587,LATS2/JAG1/FGF2/TP63/CTNNB1/YAP1,6
GO:0032233,positive regulation of actin filament bundle assembly,4/87,54/13083,0.07407407407407407,11.139208173690932,6.108537229871714,4.4772566090376206e-4,0.004174334414671506,0.002789196838813497,NF2/CCN2/SMAD3/AMOT,4
GO:0001702,gastrulation with mouth forming second,3/87,23/13083,0.13043478260869565,19.614692653673163,7.310381588219681,4.5687931201586355e-4,0.00422824101304718,0.0028252160214770044,ETS2/AMOT/CTNNB1,3
GO:0055023,positive regulation of cardiac muscle tissue growth,3/87,23/13083,0.13043478260869565,19.614692653673163,7.310381588219681,4.5687931201586355e-4,0.00422824101304718,0.0028252160214770044,CDK1/FGF2/YAP1,3
GO:0030278,regulation of ossification,5/87,97/13083,0.05154639175257732,7.751510842516886,5.460607794691064,4.616758395583444e-4,0.004256922814751205,0.0028443805595080654,CCN1/SMAD7/SMAD3/RUNX2/SMAD6,5
GO:0007389,pattern specification process,9/87,345/13083,0.02608695652173913,3.9229385307346325,4.50163682549771,4.66499182525774e-4,0.004271290446230057,0.002853980689330248,ETS2/BICC1/FGF2/SMAD2/TP63/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0010594,regulation of endothelial cell migration,6/87,149/13083,0.040268456375838924,6.0555426984494325,5.077925629852411,4.666401843169998e-4,0.004271290446230057,0.002853980689330248,ETS1/GADD45A/FGF2/SLIT2/THBS1/AMOT,6
GO:0000082,G1/S transition of mitotic cell cycle,7/87,209/13083,0.03349282296650718,5.036627619204752,4.813122613719154,4.760065329286575e-4,0.004341179580309356,0.0029006790446791295,CDK1/LATS2/MYC/CCNA1/INHBA/EGFR/SMARCA2,7
GO:0003151,outflow tract morphogenesis,4/87,56/13083,0.07142857142857142,10.741379310344827,5.9770117356721455,5.147581848678005e-4,0.004660698655770555,0.0031141745404124578,JAG1/TGFB2/CTNNB1/SMAD6,4
GO:0042698,ovulation cycle,4/87,56/13083,0.07142857142857142,10.741379310344827,5.9770117356721455,5.147581848678005e-4,0.004660698655770555,0.0031141745404124578,INHBA/TGFB2/SLIT2/EGFR,4
GO:0060479,lung cell differentiation,3/87,24/13083,0.125,18.79741379310345,7.140019621642545,5.196462201825793e-4,0.004671228387877809,0.0031212102717625583,CTNNB1/CREB1/YAP1,3
GO:0060487,lung epithelial cell differentiation,3/87,24/13083,0.125,18.79741379310345,7.140019621642545,5.196462201825793e-4,0.004671228387877809,0.0031212102717625583,CTNNB1/CREB1/YAP1,3
GO:0045786,negative regulation of cell cycle,9/87,355/13083,0.02535211267605634,3.8124332200097135,4.395498737899496,5.733472106121209e-4,0.005117702613161869,0.003419534357489169,CDK1/LATS2/ETS1/CENPF/INHBA/TAOK1/EGFR/CTNNB1/TP53BP2,9
GO:0035270,endocrine system development,5/87,102/13083,0.049019607843137254,7.371534820824882,5.285449396380644,5.813903858186627e-4,0.005117702613161869,0.003419534357489169,FGF2/SMAD2/SMAD3/GSK3B/CREB1,5
GO:0048732,gland development,9/87,356/13083,0.025280898876404494,3.8017241379310347,4.385096914055019,5.850553178123252e-4,0.005117702613161869,0.003419534357489169,TGFB2/FGF2/TGM2/SMAD2/TP63/SMAD3/EGFR/CTNNB1/CREB1,9
GO:0003382,epithelial cell morphogenesis,3/87,25/13083,0.12,18.04551724137931,6.9796509441362495,5.876787689755256e-4,0.005117702613161869,0.003419534357489169,AMOTL2/FAT1/FRMD6,3
GO:0007435,salivary gland morphogenesis,3/87,25/13083,0.12,18.04551724137931,6.9796509441362495,5.876787689755256e-4,0.005117702613161869,0.003419534357489169,TGFB2/TGM2/EGFR,3
GO:0030212,hyaluronan metabolic process,3/87,25/13083,0.12,18.04551724137931,6.9796509441362495,5.876787689755256e-4,0.005117702613161869,0.003419534357489169,FGF2/HMMR/HEXB,3
GO:0048730,epidermis morphogenesis,3/87,25/13083,0.12,18.04551724137931,6.9796509441362495,5.876787689755256e-4,0.005117702613161869,0.003419534357489169,TGFB2/TP63/CTNNB1,3
GO:0071634,regulation of transforming growth factor beta production,3/87,25/13083,0.12,18.04551724137931,6.9796509441362495,5.876787689755256e-4,0.005117702613161869,0.003419534357489169,TGFB2/THBS1/SMAD3,3
GO:2000737,negative regulation of stem cell differentiation,3/87,25/13083,0.12,18.04551724137931,6.9796509441362495,5.876787689755256e-4,0.005117702613161869,0.003419534357489169,JAG1/GSK3B/YAP1,3
GO:0008015,blood circulation,9/87,357/13083,0.025210084033613446,3.791075050709939,4.374732581170061,5.969591718413712e-4,0.005180531498194322,0.0034615152124256527,MYOF/TGFB2/DDAH1/SLIT2/SGK1/SMAD7/SMAD3/AMOT/EGFR,9
GO:0042326,negative regulation of phosphorylation,7/87,218/13083,0.03211009174311927,4.828693451439418,4.664077888424455,6.120232892469389e-4,0.005292946239418354,0.0035366282267917477,IGFBP3/LATS2/INHBA/GADD45A/SLIT2/SMAD7/WWTR1,7
GO:0098773,skin epidermis development,5/87,104/13083,0.04807692307692308,7.229774535809019,5.218674742873708,6.352854592942013e-4,0.005475243752267549,0.0036584353452572553,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0006026,aminoglycan catabolic process,3/87,26/13083,0.11538461538461539,17.351458885941646,6.828311517047825,6.611514933457e-4,0.005623200378082935,0.0037572966515185217,FGF2/HMMR/HEXB,3
GO:0060421,positive regulation of heart growth,3/87,26/13083,0.11538461538461539,17.351458885941646,6.828311517047825,6.611514933457e-4,0.005623200378082935,0.0037572966515185217,CDK1/FGF2/YAP1,3
GO:0071604,transforming growth factor beta production,3/87,26/13083,0.11538461538461539,17.351458885941646,6.828311517047825,6.611514933457e-4,0.005623200378082935,0.0037572966515185217,TGFB2/THBS1/SMAD3,3
GO:0072175,epithelial tube formation,5/87,105/13083,0.047619047619047616,7.160919540229885,5.185947896422899,6.635970741405542e-4,0.005623200378082935,0.0037572966515185217,TGFB2/FGF2/DLC1/CTNNB1/STK3,5
GO:0007162,negative regulation of cell adhesion,7/87,221/13083,0.03167420814479638,4.763145576533,4.616201426132029,6.636632025169651e-4,0.005623200378082935,0.0037572966515185217,RUNX1/NF2/JAG1/SERPINE1/THBS1/DLC1/SMAD7,7
GO:0014910,regulation of smooth muscle cell migration,4/87,60/13083,0.06666666666666667,10.025287356321838,5.732881839169079,6.697636249412476e-4,0.005655781721726091,0.0037790667762057986,IGFBP3/SERPINE1/SLIT2/FAT1,4
GO:0050921,positive regulation of chemotaxis,5/87,107/13083,0.04672897196261682,7.027070576861101,5.121764373015982,7.230457540631856e-4,0.00608523070869285,0.00406601497869513,SERPINE1/FGF2/SLIT2/THBS1/SMAD3,5
GO:0000578,embryonic axis specification,3/87,27/13083,0.1111111111111111,16.708812260536398,6.6851631120417165,7.402348808792429e-4,0.006147381063725634,0.004107542455070598,SMAD2/CTNNB1/SMAD6,3
GO:0007431,salivary gland development,3/87,27/13083,0.1111111111111111,16.708812260536398,6.6851631120417165,7.402348808792429e-4,0.006147381063725634,0.004107542455070598,TGFB2/TGM2/EGFR,3
GO:0017145,stem cell division,3/87,27/13083,0.1111111111111111,16.708812260536398,6.6851631120417165,7.402348808792429e-4,0.006147381063725634,0.004107542455070598,TGFB2/ETV5/WWTR1,3
GO:0033687,osteoblast proliferation,3/87,27/13083,0.1111111111111111,16.708812260536398,6.6851631120417165,7.402348808792429e-4,0.006147381063725634,0.004107542455070598,NF2/CCN1/SMAD3,3
GO:0001656,metanephros development,4/87,62/13083,0.06451612903225806,9.701890989988875,5.619260440701047,7.585054342892872e-4,0.006263041860271297,0.004184824410959416,MYC/CTNNB1/WWTR1/YAP1,4
GO:0031400,negative regulation of protein modification process,8/87,295/13083,0.02711864406779661,4.078082992402104,4.375038375964826,7.591565891237936e-4,0.006263041860271297,0.004184824410959416,IGFBP3/LATS2/GADD45A/SLIT2/SMAD7/GSK3B/CTNNB1/WWTR1,8
GO:0046822,regulation of nucleocytoplasmic transport,5/87,109/13083,0.045871559633027525,6.898133502056312,5.059210480980675,7.863930344331541e-4,0.006466471247076559,0.004320751374693981,PTPN14/CDK1/MDFIC/SMAD3/GSK3B,5
GO:1902105,regulation of leukocyte differentiation,7/87,228/13083,0.03070175438596491,4.616908650937688,4.507759846378075,7.976722122184853e-4,0.006537784013869154,0.004368400969562533,RUNX1/MYC/INHBA/SMAD7/CTNNB1/CREB1/SMARCA2,7
GO:0035115,embryonic forelimb morphogenesis,3/87,28/13083,0.10714285714285714,16.112068965517242,6.549472935384595,8.25095426171209e-4,0.006740518986441017,0.004503863941246578,TP63/RUNX2/CTNNB1,3
GO:0007423,sensory organ development,10/87,454/13083,0.022026431718061675,3.312319611119551,4.102826525915741,8.4010089932544e-4,0.006840821608792868,0.004570883908838347,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0070306,lens fiber cell differentiation,3/87,29/13083,0.10344827586206896,15.556480380499407,6.420597147637684,9.158956846147722e-4,0.00740989153875435,0.004951123700871705,NF2/FGF2/SMAD3,3
GO:1902742,apoptotic process involved in development,3/87,29/13083,0.10344827586206896,15.556480380499407,6.420597147637684,9.158956846147722e-4,0.00740989153875435,0.004951123700871705,CCN1/TGFB2/SLIT2,3
GO:1903035,negative regulation of response to wounding,4/87,66/13083,0.06060606060606061,9.113897596656217,5.406769870559323,9.604020509050242e-4,0.007715256564949438,0.005155161777637666,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0016331,morphogenesis of embryonic epithelium,5/87,114/13083,0.043859649122807015,6.595583787053841,4.909490579984289,9.628689413194475e-4,0.007715256564949438,0.005155161777637666,TGFB2/DLC1/TP63/CTNNB1/STK3,5
GO:0048660,regulation of smooth muscle cell proliferation,5/87,114/13083,0.043859649122807015,6.595583787053841,4.909490579984289,9.628689413194475e-4,0.007715256564949438,0.005155161777637666,IGFBP3/FGF2/THBS1/EGFR/CTNNB1,5
GO:0050767,regulation of neurogenesis,8/87,307/13083,0.026058631921824105,3.918679096933618,4.233991007822344,9.829390093317473e-4,0.007850990558611536,0.0052458561946233375,NF2/FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1/YAP1,8
GO:0014909,smooth muscle cell migration,4/87,67/13083,0.05970149253731343,8.977869274318063,5.356454182284766,0.001016245407914504,0.008091249152538338,0.005406391610358865,IGFBP3/SERPINE1/SLIT2/FAT1,4
GO:0006935,chemotaxis,8/87,309/13083,0.025889967637540454,3.8933154781832386,4.211176281421711,0.0010249117792177757,0.008108765748511612,0.005418095807785817,CCN1/SERPINE1/TGFB2/FGF2/SLIT2/THBS1/SMAD3/AMOT,8
GO:0042330,taxis,8/87,309/13083,0.025889967637540454,3.8933154781832386,4.211176281421711,0.0010249117792177757,0.008108765748511612,0.005418095807785817,CCN1/SERPINE1/TGFB2/FGF2/SLIT2/THBS1/SMAD3/AMOT,8
GO:0002040,sprouting angiogenesis,5/87,116/13083,0.04310344827586207,6.481866825208086,4.852098037458256,0.0010411299826045156,0.008185435725304467,0.005469324970488,FGF2/SLIT2/THBS1/TGM2/SMAD1,5
GO:0048754,branching morphogenesis of an epithelial tube,5/87,116/13083,0.04310344827586207,6.481866825208086,4.852098037458256,0.0010411299826045156,0.008185435725304467,0.005469324970488,MYC/FGF2/SLIT2/CTNNB1/YAP1,5
GO:0009798,axis specification,4/87,68/13083,0.058823529411764705,8.845841784989858,5.307179341164176,0.001074333630013318,0.00842008982522938,0.0056261155887539546,ETS2/SMAD2/CTNNB1/SMAD6,4
GO:0032386,regulation of intracellular transport,7/87,241/13083,0.029045643153526972,4.367863785949349,4.317561713419515,0.001102811158690002,0.008616356342662073,0.005757256483471006,NF2/PTPN14/CDK1/DAB2/MDFIC/SMAD3/GSK3B,7
GO:0043537,negative regulation of blood vessel endothelial cell migration,3/87,31/13083,0.0967741935483871,14.552836484983313,6.181079939424443,0.0011159461852072595,0.00869190382763915,0.005807735622262036,GADD45A/FGF2/THBS1,3
GO:0048659,smooth muscle cell proliferation,5/87,118/13083,0.0423728813559322,6.372004675628287,4.796041942667574,0.0011240223660613719,0.008727703077653005,0.005831655879972963,IGFBP3/FGF2/THBS1/EGFR/CTNNB1,5
GO:0030901,midbrain development,4/87,69/13083,0.057971014492753624,8.717641179410295,5.2589080129881225,0.00113471530606328,0.008767668879421073,0.005858360134323153,FGF2/YWHAQ/CTNNB1/SMAD1,4
GO:0003002,regionalization,8/87,314/13083,0.025477707006369428,3.8313200087854162,4.154963241858478,0.001136161238361981,0.008767668879421073,0.005858360134323153,ETS2/BICC1/FGF2/SMAD2/TP63/SMAD3/CTNNB1/SMAD6,8
GO:0035051,cardiocyte differentiation,5/87,119/13083,0.04201680672268908,6.318458417849899,4.768497781992567,0.001167257660292477,0.008980006785317584,0.006000239571151512,CDK1/INHBA/JAG1/TGFB2/EGFR,5
GO:0007422,peripheral nervous system development,4/87,71/13083,0.056338028169014086,8.472073822243807,5.165235751858231,0.0012625532379159777,0.009683435843098692,0.0064702551255826045,RUNX1/CDK1/PMP22/NDRG1,4
GO:0048704,embryonic skeletal system morphogenesis,4/87,72/13083,0.05555555555555555,8.354406130268199,5.119768998575264,0.0013301064925423098,0.010165432036346277,0.006792314195359385,SMAD2/SMAD3/RUNX2/CTNNB1,4
GO:0035136,forelimb morphogenesis,3/87,33/13083,0.09090909090909091,13.670846394984327,5.962785512296529,0.0013416100494539943,0.010165432036346277,0.006792314195359385,TP63/RUNX2/CTNNB1,3
GO:0060251,regulation of glial cell proliferation,3/87,33/13083,0.09090909090909091,13.670846394984327,5.962785512296529,0.0013416100494539943,0.010165432036346277,0.006792314195359385,NF2/ETV5/EGFR,3
GO:1900181,negative regulation of protein localization to nucleus,3/87,33/13083,0.09090909090909091,13.670846394984327,5.962785512296529,0.0013416100494539943,0.010165432036346277,0.006792314195359385,LATS2/MDFIC/GSK3B,3
GO:2001235,positive regulation of apoptotic signaling pathway,5/87,123/13083,0.04065040650406504,6.112980095318195,4.661396055799441,0.001352619858400016,0.01021798374960012,0.0068274280741053425,MYC/INHBA/THBS1/TP63/STK3,5
GO:0031032,actomyosin structure organization,6/87,183/13083,0.03278688524590164,4.930469191633692,4.38093625054681,0.001364531277183305,0.010277010339867054,0.006866868320770732,NF2/CCN2/DLC1/ITGB5/SMAD3/AMOT,6
GO:0032388,positive regulation of intracellular transport,5/87,124/13083,0.04032258064516129,6.063681868743047,4.6353588161938175,0.0014021723513098217,0.010528886997260577,0.007035166666515083,NF2/CDK1/DAB2/SMAD3/GSK3B,5
GO:0001666,response to hypoxia,7/87,253/13083,0.02766798418972332,4.160692381082186,4.153564981977975,0.0014597765172423727,0.01092778343838973,0.007301700341608515,MYC/INHBA/NDRG1/TGFB2/DDAH1/THBS1/SMAD3,7
GO:0060412,ventricular septum morphogenesis,3/87,34/13083,0.08823529411764706,13.268762677484789,5.860618558800371,0.0014644130252289716,0.01092778343838973,0.007301700341608515,TGFB2/SLIT2/SMAD7,3
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,4/87,74/13083,0.05405405405405406,8.128611369990681,5.031421362267541,0.0014727236053332252,0.01092778343838973,0.007301700341608515,SERPINE1/THBS1/GSK3B/STK3,4
GO:0045638,negative regulation of myeloid cell differentiation,4/87,74/13083,0.05405405405405406,8.128611369990681,5.031421362267541,0.0014727236053332252,0.01092778343838973,0.007301700341608515,RUNX1/MYC/INHBA/CTNNB1,4
GO:0010563,negative regulation of phosphorus metabolic process,7/87,254/13083,0.027559055118110236,4.144311702416508,4.140358007005949,0.001493172519891785,0.010991377605363959,0.0073441925408123145,IGFBP3/LATS2/INHBA/GADD45A/SLIT2/SMAD7/WWTR1,7
GO:0045936,negative regulation of phosphate metabolic process,7/87,254/13083,0.027559055118110236,4.144311702416508,4.140358007005949,0.001493172519891785,0.010991377605363959,0.0073441925408123145,IGFBP3/LATS2/INHBA/GADD45A/SLIT2/SMAD7/WWTR1,7
GO:0030162,regulation of proteolysis,10/87,490/13083,0.02040816326530612,3.0689655172413794,3.8192539652036275,0.0014944416919573805,0.010991377605363959,0.0073441925408123145,RUNX1/DAB2/MYC/SERPINE1/THBS1/DLC1/SMAD7/SMAD3/USP9X/GSK3B,10
GO:0030177,positive regulation of Wnt signaling pathway,5/87,126/13083,0.03968253968253968,5.96743295019157,4.584129779911687,0.0015052822021398135,0.011038736149025298,0.007375836459854056,DAB2/FGF2/SMAD3/EGFR/YAP1,5
GO:0032970,regulation of actin filament-based process,8/87,330/13083,0.024242424242424242,3.645559038662487,3.9825395299252526,0.0015586315936291257,0.011396641506769233,0.007614980810365406,NF2/CCN2/SLIT2/DLC1/TAOK1/SMAD3/AMOT/FRMD6,8
GO:0044772,mitotic cell cycle phase transition,9/87,410/13083,0.02195121951219512,3.3010092514718252,3.8731331120495316,0.0015800880276900418,0.011519944108856466,0.007697368849701793,CDK1/LATS2/CENPF/MYC/CCNA1/INHBA/TAOK1/EGFR/SMARCA2,9
GO:0060391,positive regulation of SMAD protein signal transduction,3/87,35/13083,0.08571428571428572,12.889655172413795,5.762662097186415,0.0015940512631958783,0.011554568115882262,0.007720503836348761,DAB2/INHBA/TGFB2,3
GO:1990776,response to angiotensin,3/87,35/13083,0.08571428571428572,12.889655172413795,5.762662097186415,0.0015940512631958783,0.011554568115882262,0.007720503836348761,INHBA/SMAD3/FAT1,3
GO:0031401,positive regulation of protein modification process,10/87,495/13083,0.020202020202020204,3.0379658655520725,3.781925638352979,0.0016115660519570375,0.01164786068676729,0.007782839844427737,DAB2/CCN1/TGFB2/FGF2/THBS1/UBE2D1/TAOK1/GSK3B/EGFR/ARRDC3,10
GO:0060993,kidney morphogenesis,4/87,76/13083,0.05263157894736842,7.914700544464609,4.9463341317538205,0.0016256765835059217,0.011716082963887504,0.007828424443259005,MYC/FGF2/CTNNB1/WWTR1,4
GO:0007009,plasma membrane organization,5/87,129/13083,0.03875968992248062,5.828655439722,4.5093191362423495,0.001670284572749074,0.012003076528523431,0.008020187120544489,ASAP1/MYOF/CAVIN2/NDRG1/TGFB2,5
GO:0048592,eye morphogenesis,5/87,130/13083,0.038461538461538464,5.783819628647215,4.484903854026332,0.0017281293200997834,0.012226755762846394,0.00816964457922079,JAG1/FJX1/FGF2/FAT1/CTNNB1,5
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,5/87,130/13083,0.038461538461538464,5.783819628647215,4.484903854026332,0.0017281293200997834,0.012226755762846394,0.00816964457922079,TET1/CRIM1/SMAD7/UBE2D1/SMAD6,5
GO:0022602,ovulation cycle process,3/87,36/13083,0.08333333333333333,12.531609195402298,5.668624406832038,0.001730661202476264,0.012226755762846394,0.00816964457922079,INHBA/TGFB2/SLIT2,3
GO:0032570,response to progesterone,3/87,36/13083,0.08333333333333333,12.531609195402298,5.668624406832038,0.001730661202476264,0.012226755762846394,0.00816964457922079,TGFB2/THBS1/YAP1,3
GO:0035272,exocrine system development,3/87,36/13083,0.08333333333333333,12.531609195402298,5.668624406832038,0.001730661202476264,0.012226755762846394,0.00816964457922079,TGFB2/TGM2/EGFR,3
GO:0046622,positive regulation of organ growth,3/87,36/13083,0.08333333333333333,12.531609195402298,5.668624406832038,0.001730661202476264,0.012226755762846394,0.00816964457922079,CDK1/FGF2/YAP1,3
GO:0048639,positive regulation of developmental growth,5/87,131/13083,0.03816793893129771,5.7396683337720455,4.460741222441922,0.0017874325927433865,0.012592362198315768,0.008413934617526526,CDK1/FGF2/SMAD7/CREB1/YAP1,5
GO:1903829,positive regulation of protein localization,9/87,419/13083,0.021479713603818614,3.2301045181466543,3.79610857521583,0.001833692118562982,0.012882072362341622,0.008607512465729815,NF2/AMOTL2/CDK1/TGFB2/SMAD3/GSK3B/EGFR/WWTR1/YAP1,9
GO:0001825,blastocyst formation,3/87,37/13083,0.08108108108108109,12.19291705498602,5.57824144100932,0.0018743757529117906,0.012950111086322836,0.008652974418461325,TET1/LATS2/YAP1,3
GO:0032872,regulation of stress-activated MAPK cascade,3/87,37/13083,0.08108108108108109,12.19291705498602,5.57824144100932,0.0018743757529117906,0.012950111086322836,0.008652974418461325,MYC/TGFB2/TAOK1,3
GO:0048701,embryonic cranial skeleton morphogenesis,3/87,37/13083,0.08108108108108109,12.19291705498602,5.57824144100932,0.0018743757529117906,0.012950111086322836,0.008652974418461325,SMAD2/SMAD3/RUNX2,3
GO:0060428,lung epithelium development,3/87,37/13083,0.08108108108108109,12.19291705498602,5.57824144100932,0.0018743757529117906,0.012950111086322836,0.008652974418461325,CTNNB1/CREB1/YAP1,3
GO:0045995,regulation of embryonic development,4/87,79/13083,0.05063291139240506,7.6141422959406375,4.824368205720113,0.0018753265405835144,0.012950111086322836,0.008652974418461325,CDK1/JAG1/AMOT/CTNNB1,4
GO:0033689,negative regulation of osteoblast proliferation,2/87,10/13083,0.2,30.07586206896552,7.525525241320464,0.0019001636187822954,0.012950111086322836,0.008652974418461325,NF2/SMAD3,2
GO:0060413,atrial septum morphogenesis,2/87,10/13083,0.2,30.07586206896552,7.525525241320464,0.0019001636187822954,0.012950111086322836,0.008652974418461325,CCN1/TGFB2,2
GO:0062042,regulation of cardiac epithelial to mesenchymal transition,2/87,10/13083,0.2,30.07586206896552,7.525525241320464,0.0019001636187822954,0.012950111086322836,0.008652974418461325,JAG1/TGFB2,2
GO:1901329,regulation of odontoblast differentiation,2/87,10/13083,0.2,30.07586206896552,7.525525241320464,0.0019001636187822954,0.012950111086322836,0.008652974418461325,SERPINE1/CTNNB1,2
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/87,10/13083,0.2,30.07586206896552,7.525525241320464,0.0019001636187822954,0.012950111086322836,0.008652974418461325,THBS1/STK3,2
GO:0021915,neural tube development,5/87,133/13083,0.03759398496240601,5.653357531760435,4.413155249161038,0.001910502831714294,0.012950111086322836,0.008652974418461325,MARCKS/TGFB2/PHGDH/DLC1/STK3,5
GO:0030307,positive regulation of cell growth,5/87,133/13083,0.03759398496240601,5.653357531760435,4.413155249161038,0.001910502831714294,0.012950111086322836,0.008652974418461325,TGFB2/SMAD7/TEAD1/EGFR/YAP1,5
GO:0033157,regulation of intracellular protein transport,5/87,133/13083,0.03759398496240601,5.653357531760435,4.413155249161038,0.001910502831714294,0.012950111086322836,0.008652974418461325,PTPN14/CDK1/MDFIC/SMAD3/GSK3B,5
GO:2001234,negative regulation of apoptotic signaling pathway,6/87,196/13083,0.030612244897959183,4.603448275862069,4.158744708959987,0.0019341379063359861,0.01307498077922009,0.008736409552807177,SERPINE1/FGF2/THBS1/GSK3B/CTNNB1/YAP1,6
GO:0036293,response to decreased oxygen levels,7/87,266/13083,0.02631578947368421,3.9573502722323046,3.9869633135681912,0.0019424222648577122,0.013095685592105222,0.0087502440454258,MYC/INHBA/NDRG1/TGFB2/DDAH1/THBS1/SMAD3,7
GO:0014812,muscle cell migration,4/87,80/13083,0.05,7.51896551724138,4.785130026725867,0.001964126454973442,0.013171200933351316,0.008800701706495127,IGFBP3/SERPINE1/SLIT2/FAT1,4
GO:2000177,regulation of neural precursor cell proliferation,4/87,80/13083,0.05,7.51896551724138,4.785130026725867,0.001964126454973442,0.013171200933351316,0.008800701706495127,NF2/SHCBP1/FGF2/CTNNB1,4
GO:0043114,regulation of vascular permeability,3/87,38/13083,0.07894736842105263,11.872050816696913,5.491273534945767,0.0020253243438352834,0.013545369211570374,0.009050712576521461,DDAH1/SLIT2/AMOT,3
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,4/87,81/13083,0.04938271604938271,7.426138782460621,4.746564388084272,0.002055797199799994,0.013712604726325493,0.009162455604931664,SERPINE1/THBS1/GSK3B/YAP1,4
GO:0001667,ameboidal-type cell migration,6/87,199/13083,0.03015075376884422,4.534049558135505,4.110225628188363,0.0020879615057081908,0.013890205454419475,0.00928112443693268,AMOTL2/TGFB2/FGF2/THBS1/AMOTL1/AMOT,6
GO:0010719,negative regulation of epithelial to mesenchymal transition,3/87,39/13083,0.07692307692307693,11.56763925729443,5.407502580540702,0.0021836329723103403,0.014411977617248245,0.009629760919440613,TGFB2/SMAD7/GSK3B,3
GO:0031638,zymogen activation,3/87,39/13083,0.07692307692307693,11.56763925729443,5.407502580540702,0.0021836329723103403,0.014411977617248245,0.009629760919440613,RUNX1/SERPINE1/THBS1,3
GO:0070302,regulation of stress-activated protein kinase signaling cascade,3/87,39/13083,0.07692307692307693,11.56763925729443,5.407502580540702,0.0021836329723103403,0.014411977617248245,0.009629760919440613,MYC/TGFB2/TAOK1,3
GO:0001933,negative regulation of protein phosphorylation,6/87,202/13083,0.0297029702970297,4.466712188460225,4.0626604789057925,0.0022508757583852897,0.014816788456772458,0.009900246463183812,IGFBP3/LATS2/GADD45A/SLIT2/SMAD7/WWTR1,6
GO:0045859,regulation of protein kinase activity,8/87,351/13083,0.022792022792022793,3.4274486688279793,3.7717868813064737,0.0022931100841171496,0.01494716836606286,0.00998736340081091,LATS2/CCN1/GADD45A/TGFB2/FGF2/THBS1/EGFR/WWTR1,8
GO:0010944,negative regulation of transcription by competitive promoter binding,2/87,11/13083,0.18181818181818182,27.341692789968654,7.150902404674557,0.002312400847700315,0.01494716836606286,0.00998736340081091,SMAD7/CREB1,2
GO:0018149,peptide cross-linking,2/87,11/13083,0.18181818181818182,27.341692789968654,7.150902404674557,0.002312400847700315,0.01494716836606286,0.00998736340081091,THBS1/TGM2,2
GO:0051917,regulation of fibrinolysis,2/87,11/13083,0.18181818181818182,27.341692789968654,7.150902404674557,0.002312400847700315,0.01494716836606286,0.00998736340081091,SERPINE1/THBS1,2
GO:0061101,neuroendocrine cell differentiation,2/87,11/13083,0.18181818181818182,27.341692789968654,7.150902404674557,0.002312400847700315,0.01494716836606286,0.00998736340081091,JAG1/FGF2,2
GO:0072497,mesenchymal stem cell differentiation,2/87,11/13083,0.18181818181818182,27.341692789968654,7.150902404674557,0.002312400847700315,0.01494716836606286,0.00998736340081091,GSK3B/CTNNB1,2
GO:1903377,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,2/87,11/13083,0.18181818181818182,27.341692789968654,7.150902404674557,0.002312400847700315,0.01494716836606286,0.00998736340081091,FGF2/CTNNB1,2
GO:0014013,regulation of gliogenesis,4/87,84/13083,0.047619047619047616,7.160919540229885,4.634704564362631,0.0023485061683809114,0.015069964248384282,0.010069412861339617,NF2/ETV5/EGFR/CTNNB1,4
GO:1900182,positive regulation of protein localization to nucleus,4/87,84/13083,0.047619047619047616,7.160919540229885,4.634704564362631,0.0023485061683809114,0.015069964248384282,0.010069412861339617,CDK1/SMAD3/WWTR1/YAP1,4
GO:0003197,endocardial cushion development,3/87,40/13083,0.075,11.278448275862068,5.326729591489154,0.002349424250844599,0.015069964248384282,0.010069412861339617,JAG1/TGFB2/SMAD2,3
GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,5/87,140/13083,0.03571428571428571,5.370689655172414,4.25391061156732,0.002390444657479624,0.015293967349384941,0.010219086720482173,TGFB2/FGF2/THBS1/EGFR/STK3,5
GO:0050769,positive regulation of neurogenesis,6/87,205/13083,0.02926829268292683,4.401345668629101,4.016015106352708,0.0024232191827469078,0.015464207914323779,0.010332837656175375,FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1,6
GO:0008593,regulation of Notch signaling pathway,4/87,85/13083,0.047058823529411764,7.076673427991886,4.598635007240404,0.0024521310310912053,0.015608996512631328,0.010429582157352922,JAG1/TGFB2/TP63/YAP1,4
GO:0018105,peptidyl-serine phosphorylation,5/87,141/13083,0.03546099290780142,5.332599657618,4.232035158316793,0.002465551912491423,0.015654694168426554,0.010460116308291393,CDK1/GADD45A/SMAD7/GSK3B/EGFR,5
GO:0070372,regulation of ERK1 and ERK2 cascade,6/87,206/13083,0.02912621359223301,4.379979912956143,4.000665388921738,0.0024828213720208534,0.01572453535613207,0.0105067826269463,CCN2/DAB2/CCN1/INHBA/FGF2/EGFR,6
GO:0035315,hair cell differentiation,3/87,41/13083,0.07317073170731707,11.00336417157275,5.248772596591575,0.0025228174545816693,0.01589755320625836,0.010622389282449133,JAG1/FGF2/CTNNB1,3
GO:0045620,negative regulation of lymphocyte differentiation,3/87,41/13083,0.07317073170731707,11.00336417157275,5.248772596591575,0.0025228174545816693,0.01589755320625836,0.010622389282449133,RUNX1/INHBA/SMAD7,3
GO:0060840,artery development,4/87,87/13083,0.04597701149425287,6.913991280221958,4.528217744188547,0.002668742723432703,0.016733016875923046,0.011180627409749639,JAG1/TGFB2/SMAD7/SMAD6,4
GO:0097306,cellular response to alcohol,4/87,87/13083,0.04597701149425287,6.913991280221958,4.528217744188547,0.002668742723432703,0.016733016875923046,0.011180627409749639,INHBA/SGK1/CTNNB1/CREB1,4
GO:0003208,cardiac ventricle morphogenesis,3/87,42/13083,0.07142857142857142,10.741379310344827,5.173464810199083,0.0027039285679767043,0.016827426423041126,0.011243709756350822,JAG1/TGFB2/SMAD7,3
GO:0035196,miRNA processing,3/87,42/13083,0.07142857142857142,10.741379310344827,5.173464810199083,0.0027039285679767043,0.016827426423041126,0.011243709756350822,SMAD2/SMAD3/SMAD1,3
GO:0042181,ketone biosynthetic process,3/87,42/13083,0.07142857142857142,10.741379310344827,5.173464810199083,0.0027039285679767043,0.016827426423041126,0.011243709756350822,DAB2/INHBA/CREB1,3
GO:0002076,osteoblast development,2/87,12/13083,0.16666666666666666,25.063218390804597,6.823100617243506,0.002762913193259842,0.017067453913043554,0.011404090753615937,SMAD3/RUNX2,2
GO:0060039,pericardium development,2/87,12/13083,0.16666666666666666,25.063218390804597,6.823100617243506,0.002762913193259842,0.017067453913043554,0.011404090753615937,SMAD2/SMAD3,2
GO:0061029,eyelid development in camera-type eye,2/87,12/13083,0.16666666666666666,25.063218390804597,6.823100617243506,0.002762913193259842,0.017067453913043554,0.011404090753615937,INHBA/EGFR,2
GO:0051960,regulation of nervous system development,8/87,365/13083,0.021917808219178082,3.2959848842701938,3.6399707503585486,0.002917931313280862,0.017980765930487475,0.012014345404741063,NF2/FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1/YAP1,8
GO:0030010,establishment of cell polarity,5/87,148/13083,0.033783783783783786,5.080382106244175,4.084513378751244,0.0030402481232421233,0.01868858405169423,0.012487293633130702,AMOTL2/AMOTL1/GSK3B/AMOT/FAT1,5
GO:0010001,glial cell differentiation,6/87,215/13083,0.027906976744186046,4.19663191659984,3.8667685936610035,0.0030702106628023905,0.01881567669348449,0.012572214092179679,CDK1/NDRG1/FGF2/PHGDH/EGFR/CTNNB1,6
GO:0001658,branching involved in ureteric bud morphogenesis,3/87,44/13083,0.06818181818181818,10.253134796238244,5.030196281126978,0.003089752284597416,0.01881567669348449,0.012572214092179679,MYC/FGF2/CTNNB1,3
GO:0035987,endodermal cell differentiation,3/87,44/13083,0.06818181818181818,10.253134796238244,5.030196281126978,0.003089752284597416,0.01881567669348449,0.012572214092179679,INHBA/ITGB5/CTNNB1,3
GO:0070482,response to oxygen levels,7/87,289/13083,0.02422145328719723,3.6424054408781767,3.7165249311850586,0.003090932534974326,0.01881567669348449,0.012572214092179679,MYC/INHBA/NDRG1/TGFB2/DDAH1/THBS1/SMAD3,7
GO:0002683,negative regulation of immune system process,8/87,370/13083,0.021621621621621623,3.251444547996272,3.5944292596282046,0.003170800936960469,0.019255130145028707,0.012865847054010617,RUNX1/MYC/INHBA/TGFB2/SLIT2/THBS1/SMAD7/CTNNB1,8
GO:0003215,cardiac right ventricle morphogenesis,2/87,13/13083,0.15384615384615385,23.13527851458886,6.532970852460454,0.0032511852169154897,0.019553890944901793,0.013065472334543632,JAG1/TGFB2,2
GO:0034333,adherens junction assembly,2/87,13/13083,0.15384615384615385,23.13527851458886,6.532970852460454,0.0032511852169154897,0.019553890944901793,0.013065472334543632,SMAD7/CTNNB1,2
GO:0038092,nodal signaling pathway,2/87,13/13083,0.15384615384615385,23.13527851458886,6.532970852460454,0.0032511852169154897,0.019553890944901793,0.013065472334543632,SMAD2/SMAD3,2
GO:0048820,hair follicle maturation,2/87,13/13083,0.15384615384615385,23.13527851458886,6.532970852460454,0.0032511852169154897,0.019553890944901793,0.013065472334543632,TGFB2/CTNNB1,2
GO:0090263,positive regulation of canonical Wnt signaling pathway,4/87,92/13083,0.043478260869565216,6.538230884557721,4.361496485384577,0.0032670251611394605,0.019602150966836762,0.013097718601193707,FGF2/SMAD3/EGFR/YAP1,4
GO:0045930,negative regulation of mitotic cell cycle,6/87,218/13083,0.027522935779816515,4.138880101233787,3.823753836723606,0.003287404136702661,0.01962721968439846,0.01311446895725776,CDK1/CENPF/INHBA/TAOK1/EGFR/CTNNB1,6
GO:0021795,cerebral cortex cell migration,3/87,45/13083,0.06666666666666667,10.025287356321838,4.961964515943959,0.00329468081624073,0.01962721968439846,0.01311446895725776,SLIT2/EGFR/CTNNB1,3
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,3/87,45/13083,0.06666666666666667,10.025287356321838,4.961964515943959,0.00329468081624073,0.01962721968439846,0.01311446895725776,INHBA/THBS1/STK3,3
GO:0018209,peptidyl-serine modification,5/87,151/13083,0.033112582781456956,4.97944736241151,4.024113648904029,0.0033140037012802186,0.019695548063532672,0.013160124451080338,CDK1/GADD45A/SMAD7/GSK3B/EGFR,5
GO:0010638,positive regulation of organelle organization,9/87,458/13083,0.019650655021834062,2.9550519500075287,3.4847144401510537,0.0033357815399122897,0.01977810898841613,0.013215289813463642,ASAP1/NF2/CDK1/CCN2/MYC/SMAD3/GSK3B/AMOT/CTNNB1,9
GO:0071396,cellular response to lipid,9/87,461/13083,0.019522776572668113,2.9358216770139873,3.462131591380512,0.0034827951379716145,0.020601061806681156,0.013765168469838156,DAB2/INHBA/SERPINE1/SGK1/TP63/GSK3B/EGFR/CREB1/YAP1,9
GO:0044057,regulation of system process,8/87,376/13083,0.02127659574468085,3.1995597945707996,3.5407888383092008,0.0034964877874490785,0.020633391460993623,0.013786770421347202,DAB2/INHBA/TGFB2/GLS/SGK1/SMAD7/SMAD3/EGFR,8
GO:0048144,fibroblast proliferation,4/87,94/13083,0.0425531914893617,6.399119589141599,4.298241993386315,0.0035299899173606977,0.020782194161362982,0.013886197055691205,CDK1/MYC/EGFR/CTNNB1,4
GO:0043549,regulation of kinase activity,8/87,377/13083,0.021220159151193633,3.1910728985639802,3.531953067608541,0.0035532111992117596,0.02086991495930467,0.013944810129779663,LATS2/CCN1/GADD45A/TGFB2/FGF2/THBS1/EGFR/WWTR1,8
GO:0001838,embryonic epithelial tube formation,4/87,95/13083,0.042105263157894736,6.331760435571687,4.267299626120405,0.0036667188671738768,0.02143620260809343,0.014323190863797842,TGFB2/DLC1/CTNNB1/STK3,4
GO:0030216,keratinocyte differentiation,4/87,95/13083,0.042105263157894736,6.331760435571687,4.267299626120405,0.0036667188671738768,0.02143620260809343,0.014323190863797842,LATS2/JAG1/TP63/YAP1,4
GO:0050920,regulation of chemotaxis,5/87,155/13083,0.03225806451612903,4.850945494994438,3.946021039878196,0.0037061075040644978,0.021599426919094528,0.014432253695625992,SERPINE1/FGF2/SLIT2/THBS1/SMAD3,5
GO:0032956,regulation of actin cytoskeleton organization,7/87,299/13083,0.023411371237458192,3.5205858609156957,3.6074104276560024,0.003728118864047848,0.021599426919094528,0.014432253695625992,NF2/CCN2/SLIT2/DLC1/TAOK1/SMAD3/AMOT,7
GO:0014009,glial cell proliferation,3/87,47/13083,0.06382978723404255,9.598679383712398,4.831704396326076,0.003729087661869191,0.021599426919094528,0.014432253695625992,NF2/ETV5/EGFR,3
GO:0030858,positive regulation of epithelial cell differentiation,3/87,47/13083,0.06382978723404255,9.598679383712398,4.831704396326076,0.003729087661869191,0.021599426919094528,0.014432253695625992,SERPINE1/FGF2/CTNNB1,3
GO:0048485,sympathetic nervous system development,2/87,14/13083,0.14285714285714285,21.482758620689655,6.273691127981223,0.0037767065058289767,0.02167501125084456,0.014482757454606119,TP63/CTNNB1,2
GO:0051895,negative regulation of focal adhesion assembly,2/87,14/13083,0.14285714285714285,21.482758620689655,6.273691127981223,0.0037767065058289767,0.02167501125084456,0.014482757454606119,THBS1/DLC1,2
GO:0071636,positive regulation of transforming growth factor beta production,2/87,14/13083,0.14285714285714285,21.482758620689655,6.273691127981223,0.0037767065058289767,0.02167501125084456,0.014482757454606119,THBS1/SMAD3,2
GO:0150118,negative regulation of cell-substrate junction organization,2/87,14/13083,0.14285714285714285,21.482758620689655,6.273691127981223,0.0037767065058289767,0.02167501125084456,0.014482757454606119,THBS1/DLC1,2
GO:0010595,positive regulation of endothelial cell migration,4/87,96/13083,0.041666666666666664,6.265804597701149,4.236798239771317,0.003807004108941545,0.021799009829281724,0.014565610529764333,ETS1/FGF2/THBS1/AMOT,4
GO:0046887,positive regulation of hormone secretion,4/87,97/13083,0.041237113402061855,6.201208674013508,4.206726655651061,0.003950889195796742,0.02251378358449039,0.015043206357134515,DAB2/INHBA/EGFR/CREB1,4
GO:0061041,regulation of wound healing,4/87,97/13083,0.041237113402061855,6.201208674013508,4.206726655651061,0.003950889195796742,0.02251378358449039,0.015043206357134515,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0001738,morphogenesis of a polarized epithelium,3/87,48/13083,0.0625,9.398706896551724,4.769461786789582,0.003958763381483358,0.02251378358449039,0.015043206357134515,TP63/FAT1/YAP1,3
GO:0048645,animal organ formation,3/87,49/13083,0.061224489795918366,9.206896551724139,4.709014071577772,0.004196880577238458,0.02381397395410419,0.01591196446526226,FGF2/TP63/CTNNB1,3
GO:0048706,embryonic skeletal system development,4/87,99/13083,0.04040404040404041,6.075931731104145,4.147830145817866,0.004249631547606238,0.02405886212504841,0.016075593260755923,SMAD2/SMAD3/RUNX2/CTNNB1,4
GO:0001759,organ induction,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,FGF2/CTNNB1,2
GO:0032926,negative regulation of activin receptor signaling pathway,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,SMAD7/SMAD6,2
GO:0034616,response to laminar fluid shear stress,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,SMAD7/SMAD6,2
GO:0042730,fibrinolysis,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,SERPINE1/THBS1,2
GO:0048368,lateral mesoderm development,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,SMAD2/YAP1,2
GO:1900119,positive regulation of execution phase of apoptosis,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,DLC1/TP53BP2,2
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,FGF2/THBS1,2
GO:2000738,positive regulation of stem cell differentiation,2/87,15/13083,0.13333333333333333,20.050574712643677,6.040056427137291,0.004338971630072124,0.02412891540625474,0.01612240129554165,TGFB2/FGF2,2
GO:0002042,cell migration involved in sprouting angiogenesis,3/87,50/13083,0.06,9.022758620689656,4.650272232662683,0.0044435305280486025,0.024547080538206815,0.016401809878630592,FGF2/SLIT2/THBS1,3
GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,3/87,50/13083,0.06,9.022758620689656,4.650272232662683,0.0044435305280486025,0.024547080538206815,0.016401809878630592,SLIT2/ARRDC3/YWHAB,3
GO:0071300,cellular response to retinoic acid,3/87,50/13083,0.06,9.022758620689656,4.650272232662683,0.0044435305280486025,0.024547080538206815,0.016401809878630592,GSK3B/CREB1/YAP1,3
GO:0045446,endothelial cell differentiation,4/87,101/13083,0.039603960396039604,5.955616251280301,4.090528287855168,0.004563287973563549,0.025153244478455784,0.016806835058214387,AMOTL2/JAG1/FSTL1/CTNNB1,4
GO:0021537,telencephalon development,6/87,234/13083,0.02564102564102564,3.8558797524314765,3.606658551967364,0.004645094186942702,0.025492114268823408,0.017033260268600213,NF2/INHBA/SLIT2/GSK3B/EGFR/CTNNB1,6
GO:0110053,regulation of actin filament organization,6/87,234/13083,0.02564102564102564,3.8558797524314765,3.606658551967364,0.004645094186942702,0.025492114268823408,0.017033260268600213,NF2/CCN2/SLIT2/DLC1/SMAD3/AMOT,6
GO:0051403,stress-activated MAPK cascade,3/87,51/13083,0.058823529411764705,8.845841784989858,4.59315335640656,0.004698801619783729,0.025671912282828613,0.017153397277874235,MYC/TGFB2/TAOK1,3
GO:0060675,ureteric bud morphogenesis,3/87,51/13083,0.058823529411764705,8.845841784989858,4.59315335640656,0.004698801619783729,0.025671912282828613,0.017153397277874235,MYC/FGF2/CTNNB1,3
GO:0007623,circadian rhythm,5/87,164/13083,0.03048780487804878,4.584735071488646,3.779691788147,0.004708564453788342,0.025671912282828613,0.017153397277874235,CDK1/USP9X/GSK3B/EGFR/CREB1,5
GO:0022612,gland morphogenesis,4/87,102/13083,0.0392156862745098,5.897227856659905,4.06245131617605,0.004725814405716401,0.025710070562986406,0.017178893786734806,TGFB2/TGM2/TP63/EGFR,4
GO:0009410,response to xenobiotic stimulus,7/87,313/13083,0.022364217252396165,3.3631155668172306,3.462210973872997,0.0047828694040330175,0.025964148193322097,0.01734866277334373,CDK1/CENPF/MYC/THBS1/EGFR/CTNNB1/CREB1,7
GO:0051348,negative regulation of transferase activity,5/87,165/13083,0.030303030303030304,4.556948798328109,3.761956704177131,0.004830745086533556,0.026105230378851187,0.0174429307324482,LATS2/GADD45A/SMAD7/GSK3B/WWTR1,5
GO:0072331,signal transduction by p53 class mediator,5/87,165/13083,0.030303030303030304,4.556948798328109,3.761956704177131,0.004830745086533556,0.026105230378851187,0.0174429307324482,MYC/NDRG1/SGK1/TP63/TP53BP2,5
GO:0051962,positive regulation of nervous system development,6/87,236/13083,0.025423728813559324,3.823202805376973,3.5808741971657927,0.0048400845798109255,0.026105230378851187,0.0174429307324482,FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1,6
GO:0001824,blastocyst development,4/87,103/13083,0.038834951456310676,5.839973217274857,4.034744812677332,0.00489219520316361,0.02632966860415093,0.017592895331909796,TET1/GINS1/LATS2/YAP1,4
GO:0043586,tongue development,2/87,16/13083,0.125,18.79741379310345,5.828016747979805,0.004937480100166642,0.026426009984524972,0.017657268486260286,EGFR/CTNNB1,2
GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,2/87,16/13083,0.125,18.79741379310345,5.828016747979805,0.004937480100166642,0.026426009984524972,0.017657268486260286,FGF2/CTNNB1,2
GO:0022029,telencephalon cell migration,3/87,52/13083,0.057692307692307696,8.675729442970823,4.5375801044034905,0.004962779387045958,0.026426009984524972,0.017657268486260286,SLIT2/EGFR/CTNNB1,3
GO:0035904,aorta development,3/87,52/13083,0.057692307692307696,8.675729442970823,4.5375801044034905,0.004962779387045958,0.026426009984524972,0.017657268486260286,JAG1/TGFB2/SMAD6,3
GO:0072171,mesonephric tubule morphogenesis,3/87,52/13083,0.057692307692307696,8.675729442970823,4.5375801044034905,0.004962779387045958,0.026426009984524972,0.017657268486260286,MYC/FGF2/CTNNB1,3
GO:0030326,embryonic limb morphogenesis,4/87,104/13083,0.038461538461538464,5.783819628647215,4.007400031411031,0.005062471592918393,0.026842872632218455,0.017935806778515813,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0035113,embryonic appendage morphogenesis,4/87,104/13083,0.038461538461538464,5.783819628647215,4.007400031411031,0.005062471592918393,0.026842872632218455,0.017935806778515813,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0021543,pallium development,5/87,167/13083,0.029940119760479042,4.502374561222383,3.72690784914098,0.005081850536728893,0.026888778789274394,0.01796648024533066,NF2/SLIT2/GSK3B/EGFR/CTNNB1,5
GO:0051347,positive regulation of transferase activity,6/87,239/13083,0.02510460251046025,3.77521281200404,3.5427209144961567,0.0051438051618101655,0.027159291254357676,0.01814723062072417,CCN1/TGFB2/FGF2/THBS1/EGFR/ARRDC3,6
GO:0021536,diencephalon development,3/87,53/13083,0.05660377358490566,8.512036434612883,4.483480239386328,0.00523554655448161,0.027412840832233564,0.018316646774496695,FGF2/CTNNB1/CREB1,3
GO:0035019,somatic stem cell population maintenance,3/87,53/13083,0.05660377358490566,8.512036434612883,4.483480239386328,0.00523554655448161,0.027412840832233564,0.018316646774496695,MYC/TP63/YAP1,3
GO:0042306,regulation of protein import into nucleus,3/87,53/13083,0.05660377358490566,8.512036434612883,4.483480239386328,0.00523554655448161,0.027412840832233564,0.018316646774496695,CDK1/MDFIC/SMAD3,3
GO:0070918,regulatory ncRNA processing,3/87,53/13083,0.05660377358490566,8.512036434612883,4.483480239386328,0.00523554655448161,0.027412840832233564,0.018316646774496695,SMAD2/SMAD3/SMAD1,3
GO:0072593,reactive oxygen species metabolic process,5/87,170/13083,0.029411764705882353,4.422920892494929,3.6753575483460104,0.005475699451065492,0.02857651268506178,0.019094186264844434,CCN2/CCN1/GADD45A/THBS1/EGFR,5
GO:0021885,forebrain cell migration,3/87,54/13083,0.05555555555555555,8.354406130268199,4.43078619954859,0.0055171830776332385,0.02857651268506178,0.019094186264844434,SLIT2/EGFR/CTNNB1,3
GO:0031098,stress-activated protein kinase signaling cascade,3/87,54/13083,0.05555555555555555,8.354406130268199,4.43078619954859,0.0055171830776332385,0.02857651268506178,0.019094186264844434,MYC/TGFB2/TAOK1,3
GO:0070613,regulation of protein processing,3/87,54/13083,0.05555555555555555,8.354406130268199,4.43078619954859,0.0055171830776332385,0.02857651268506178,0.019094186264844434,RUNX1/SERPINE1/THBS1,3
GO:0003283,atrial septum development,2/87,17/13083,0.11764705882352941,17.691683569979716,5.634366901575595,0.005571736324958218,0.02857651268506178,0.019094186264844434,CCN1/TGFB2,2
GO:0023019,signal transduction involved in regulation of gene expression,2/87,17/13083,0.11764705882352941,17.691683569979716,5.634366901575595,0.005571736324958218,0.02857651268506178,0.019094186264844434,SMAD2/SMAD3,2
GO:0033137,negative regulation of peptidyl-serine phosphorylation,2/87,17/13083,0.11764705882352941,17.691683569979716,5.634366901575595,0.005571736324958218,0.02857651268506178,0.019094186264844434,GADD45A/SMAD7,2
GO:0062009,secondary palate development,2/87,17/13083,0.11764705882352941,17.691683569979716,5.634366901575595,0.005571736324958218,0.02857651268506178,0.019094186264844434,TGFB2/SMAD2,2
GO:0072234,metanephric nephron tubule development,2/87,17/13083,0.11764705882352941,17.691683569979716,5.634366901575595,0.005571736324958218,0.02857651268506178,0.019094186264844434,WWTR1/YAP1,2
GO:2001026,regulation of endothelial cell chemotaxis,2/87,17/13083,0.11764705882352941,17.691683569979716,5.634366901575595,0.005571736324958218,0.02857651268506178,0.019094186264844434,FGF2/THBS1,2
GO:0048593,camera-type eye morphogenesis,4/87,107/13083,0.037383177570093455,5.6216564614888815,3.9274528325003852,0.005597081200153323,0.02863047936184994,0.019130245590558675,JAG1/FJX1/FAT1/CTNNB1,4
GO:0032870,cellular response to hormone stimulus,9/87,496/13083,0.018145161290322582,2.7286568409343714,3.2112961505077524,0.0056050898591181505,0.02863047936184994,0.019130245590558675,LATS2/DAB2/INHBA/SLIT2/SGK1/TP63/GSK3B/FAT1/EGFR,9
GO:0010811,positive regulation of cell-substrate adhesion,4/87,108/13083,0.037037037037037035,5.569604086845466,3.9014730923899803,0.005783345009690579,0.02942601532890405,0.01966180492051341,DAB2/CCN1/SMAD3/GSK3B,4
GO:0008347,glial cell migration,3/87,55/13083,0.05454545454545454,8.202507836990595,4.3794347155411275,0.005807766183336326,0.02942601532890405,0.01966180492051341,TGFB2/HEXB/CTNNB1,3
GO:0051058,negative regulation of small GTPase mediated signal transduction,3/87,55/13083,0.05454545454545454,8.202507836990595,4.3794347155411275,0.005807766183336326,0.02942601532890405,0.01966180492051341,TGFB2/SLIT2/DLC1,3
GO:2000379,positive regulation of reactive oxygen species metabolic process,3/87,55/13083,0.05454545454545454,8.202507836990595,4.3794347155411275,0.005807766183336326,0.02942601532890405,0.01966180492051341,GADD45A/THBS1/EGFR,3
GO:0002011,morphogenesis of an epithelial sheet,3/87,56/13083,0.05357142857142857,8.056034482758621,4.329366465174912,0.0061073704096647405,0.030632199454236057,0.020467750159969697,CCN1/JAG1/ITGB5,3
GO:0003148,outflow tract septum morphogenesis,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,TGFB2/SMAD6,2
GO:0009065,glutamine family amino acid catabolic process,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,GLS/DDAH1,2
GO:0010566,regulation of ketone biosynthetic process,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,DAB2/CREB1,2
GO:0035929,steroid hormone secretion,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,DAB2/INHBA,2
GO:0036303,lymph vessel morphogenesis,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,PTPN14/FGF2,2
GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,FGF2/CTNNB1,2
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,FGF2/THBS1,2
GO:0045844,positive regulation of striated muscle tissue development,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,CTNNB1/CREB1,2
GO:0048636,positive regulation of muscle organ development,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,CTNNB1/CREB1,2
GO:0060392,negative regulation of SMAD protein signal transduction,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,SMAD7/SMAD6,2
GO:0072170,metanephric tubule development,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,WWTR1/YAP1,2
GO:0072243,metanephric nephron epithelium development,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,WWTR1/YAP1,2
GO:0090025,regulation of monocyte chemotaxis,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,SERPINE1/SLIT2,2
GO:1901863,positive regulation of muscle tissue development,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,CTNNB1/CREB1,2
GO:1904044,response to aldosterone,2/87,18/13083,0.1111111111111111,16.708812260536398,5.456532449699004,0.006241249569822418,0.030632199454236057,0.020467750159969697,INHBA/SGK1,2
GO:0009612,response to mechanical stimulus,5/87,176/13083,0.028409090909090908,4.272139498432602,3.575751558201258,0.006327446989542192,0.03099460361283558,0.020709900508534475,GADD45A/FGF2/THBS1/EGFR/CTNNB1,5
GO:0009799,specification of symmetry,4/87,111/13083,0.036036036036036036,5.419074246660454,3.825437978214085,0.006366869667799031,0.031066360168949363,0.02075784663349592,BICC1/SMAD2/SMAD3/CTNNB1,4
GO:0009855,determination of bilateral symmetry,4/87,111/13083,0.036036036036036036,5.419074246660454,3.825437978214085,0.006366869667799031,0.031066360168949363,0.02075784663349592,BICC1/SMAD2/SMAD3/CTNNB1,4
GO:0043525,positive regulation of neuron apoptotic process,3/87,57/13083,0.05263157894736842,7.914700544464609,4.280525761517281,0.006416067645429548,0.031185072974297103,0.020837167873365644,TGFB2/GSK3B/CTNNB1,3
GO:2000027,regulation of animal organ morphogenesis,3/87,57/13083,0.05263157894736842,7.914700544464609,4.280525761517281,0.006416067645429548,0.031185072974297103,0.020837167873365644,FGF2/RUNX2/CTNNB1,3
GO:0050680,negative regulation of epithelial cell proliferation,4/87,112/13083,0.03571428571428571,5.370689655172414,3.800704448195269,0.006569751019175484,0.03187028153983001,0.021295008902631307,DAB2/TGFB2/THBS1/STK3,4
GO:0046824,positive regulation of nucleocytoplasmic transport,3/87,58/13083,0.05172413793103448,7.778240190249703,4.232860270628473,0.006733927169235475,0.03247824873162033,0.02170123897454023,CDK1/SMAD3/GSK3B,3
GO:0051893,regulation of focal adhesion assembly,3/87,58/13083,0.05172413793103448,7.778240190249703,4.232860270628473,0.006733927169235475,0.03247824873162033,0.02170123897454023,THBS1/DLC1/SMAD3,3
GO:0090109,regulation of cell-substrate junction assembly,3/87,58/13083,0.05172413793103448,7.778240190249703,4.232860270628473,0.006733927169235475,0.03247824873162033,0.02170123897454023,THBS1/DLC1/SMAD3,3
GO:0002573,myeloid leukocyte differentiation,5/87,180/13083,0.027777777777777776,4.1772030651340994,3.5117834203886145,0.006944595502774443,0.032991286097199646,0.02204403906100135,RUNX1/MYC/INHBA/CTNNB1/CREB1,5
GO:0003156,regulation of animal organ formation,2/87,19/13083,0.10526315789473684,15.829401088929218,5.292418436092264,0.006945533915199925,0.032991286097199646,0.02204403906100135,FGF2/CTNNB1,2
GO:0007263,nitric oxide mediated signal transduction,2/87,19/13083,0.10526315789473684,15.829401088929218,5.292418436092264,0.006945533915199925,0.032991286097199646,0.02204403906100135,DDAH1/THBS1,2
GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",2/87,19/13083,0.10526315789473684,15.829401088929218,5.292418436092264,0.006945533915199925,0.032991286097199646,0.02204403906100135,RUNX1/SMAD7,2
GO:0060561,apoptotic process involved in morphogenesis,2/87,19/13083,0.10526315789473684,15.829401088929218,5.292418436092264,0.006945533915199925,0.032991286097199646,0.02204403906100135,CCN1/TGFB2,2
GO:0072207,metanephric epithelium development,2/87,19/13083,0.10526315789473684,15.829401088929218,5.292418436092264,0.006945533915199925,0.032991286097199646,0.02204403906100135,WWTR1/YAP1,2
GO:0097320,plasma membrane tubulation,2/87,19/13083,0.10526315789473684,15.829401088929218,5.292418436092264,0.006945533915199925,0.032991286097199646,0.02204403906100135,ASAP1/CAVIN2,2
GO:2000641,regulation of early endosome to late endosome transport,2/87,19/13083,0.10526315789473684,15.829401088929218,5.292418436092264,0.006945533915199925,0.032991286097199646,0.02204403906100135,NF2/DAB2,2
GO:0031016,pancreas development,3/87,59/13083,0.05084745762711865,7.646405610753946,4.1863207556639805,0.007061015688099203,0.033287645386753384,0.02224205970608217,SMAD2/GSK3B/CTNNB1,3
GO:0048844,artery morphogenesis,3/87,59/13083,0.05084745762711865,7.646405610753946,4.1863207556639805,0.007061015688099203,0.033287645386753384,0.02224205970608217,JAG1/TGFB2/SMAD7,3
GO:0072078,nephron tubule morphogenesis,3/87,59/13083,0.05084745762711865,7.646405610753946,4.1863207556639805,0.007061015688099203,0.033287645386753384,0.02224205970608217,MYC/FGF2/CTNNB1,3
GO:1903317,regulation of protein maturation,3/87,59/13083,0.05084745762711865,7.646405610753946,4.1863207556639805,0.007061015688099203,0.033287645386753384,0.02224205970608217,RUNX1/SERPINE1/THBS1,3
GO:0043086,negative regulation of catalytic activity,7/87,337/13083,0.020771513353115726,3.12360585285992,3.231422572694685,0.0070971433236751355,0.033370691714289455,0.022297549403655165,LATS2/GADD45A/SERPINE1/THBS1/SMAD7/GSK3B/WWTR1,7
GO:0052548,regulation of endopeptidase activity,5/87,181/13083,0.027624309392265192,4.154124595160983,3.496080797350543,0.007105242972659715,0.033370691714289455,0.022297549403655165,MYC/SERPINE1/THBS1/DLC1/SMAD3,5
GO:0007043,cell-cell junction assembly,4/87,115/13083,0.034782608695652174,5.230584707646177,3.728246869277657,0.007204044046750942,0.03377148125093713,0.02256534800280866,SMAD7/MPDZ/AMOT/CTNNB1,4
GO:0021987,cerebral cortex development,4/87,116/13083,0.034482758620689655,5.185493460166469,3.7046548651055935,0.00742414812047046,0.03472117221877965,0.023199910254468728,SLIT2/GSK3B/EGFR/CTNNB1,4
GO:0048705,skeletal system morphogenesis,5/87,183/13083,0.0273224043715847,4.1087243263614095,3.465012045712703,0.007434317975073633,0.03472117221877965,0.023199910254468728,CCN2/SMAD2/SMAD3/RUNX2/CTNNB1,5
GO:0031960,response to corticosteroid,4/87,117/13083,0.03418803418803419,5.14117300324197,3.6813333375561714,0.007648649405729673,0.03555672214828468,0.02375820601866415,INHBA/SLIT2/SGK1/EGFR,4
GO:0002053,positive regulation of mesenchymal cell proliferation,2/87,20/13083,0.1,15.03793103448276,5.140300237620316,0.007684108215458652,0.03555672214828468,0.02375820601866415,MYC/CTNNB1,2
GO:0003209,cardiac atrium morphogenesis,2/87,20/13083,0.1,15.03793103448276,5.140300237620316,0.007684108215458652,0.03555672214828468,0.02375820601866415,CCN1/TGFB2,2
GO:1901983,regulation of protein acetylation,2/87,20/13083,0.1,15.03793103448276,5.140300237620316,0.007684108215458652,0.03555672214828468,0.02375820601866415,TAOK1/GSK3B,2
GO:1902074,response to salt,2/87,20/13083,0.1,15.03793103448276,5.140300237620316,0.007684108215458652,0.03555672214828468,0.02375820601866415,DAB2/RUNX2,2
GO:0009064,glutamine family amino acid metabolic process,3/87,61/13083,0.04918032786885246,7.395703787450537,4.096436818222768,0.007743133909803682,0.035632623570252535,0.023808921650231695,GLS/DDAH1/PHGDH,3
GO:0072028,nephron morphogenesis,3/87,61/13083,0.04918032786885246,7.395703787450537,4.096436818222768,0.007743133909803682,0.035632623570252535,0.023808921650231695,MYC/FGF2/CTNNB1,3
GO:0072088,nephron epithelium morphogenesis,3/87,61/13083,0.04918032786885246,7.395703787450537,4.096436818222768,0.007743133909803682,0.035632623570252535,0.023808921650231695,MYC/FGF2/CTNNB1,3
GO:0031396,regulation of protein ubiquitination,5/87,185/13083,0.02702702702702703,4.0643056849953405,3.434382101892676,0.007773905712134012,0.035708709754637545,0.0238597607359116,SMAD7/UBE2D1/GSK3B/CTNNB1/ARRDC3,5
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/87,118/13083,0.03389830508474576,5.09760374050263,3.6582766751936426,0.007877583687823304,0.036118793215833354,0.024133769327460215,MYC/THBS1/DLC1/SMAD3,4
GO:0030099,myeloid cell differentiation,7/87,345/13083,0.020289855072463767,3.051174412793603,3.159027182767884,0.008028331131291333,0.03674280014101946,0.02455071679027238,RUNX1/ETS1/MYC/INHBA/JAG1/CTNNB1/CREB1,7
GO:0033135,regulation of peptidyl-serine phosphorylation,3/87,62/13083,0.04838709677419355,7.276418242491657,4.053007418721163,0.00809828451025355,0.0369954418064042,0.02471952629723641,GADD45A/SMAD7/EGFR,3
GO:0048588,developmental cell growth,5/87,187/13083,0.026737967914438502,4.02083717499539,3.40417952750987,0.008124172079701463,0.03704622468343867,0.02475345827920522,SLIT2/SMAD7/USP9X/GSK3B/CTNNB1,5
GO:0023061,signal release,7/87,347/13083,0.020172910662824207,3.033588393123323,3.141254429587646,0.00827463913554722,0.03749994379124374,0.025056623233299765,DAB2/MYOF/INHBA/TGM2/SMAD2/EGFR/CREB1,7
GO:0003158,endothelium development,4/87,120/13083,0.03333333333333333,5.012643678160919,3.612936312675812,0.008348892281422372,0.03749994379124374,0.025056623233299765,AMOTL2/JAG1/FSTL1/CTNNB1,4
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,4/87,120/13083,0.03333333333333333,5.012643678160919,3.612936312675812,0.008348892281422372,0.03749994379124374,0.025056623233299765,DAB2/SMAD7/USP9X/GSK3B,4
GO:1902903,regulation of supramolecular fiber organization,7/87,348/13083,0.020114942528735632,3.024871185097106,3.132415720667382,0.008399869789139692,0.03749994379124374,0.025056623233299765,NF2/CCN2/SLIT2/DLC1/TAOK1/SMAD3/AMOT,7
GO:0030194,positive regulation of blood coagulation,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,SERPINE1/THBS1,2
GO:0032874,positive regulation of stress-activated MAPK cascade,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,TGFB2/TAOK1,2
GO:0032925,regulation of activin receptor signaling pathway,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,SMAD7/SMAD6,2
GO:0035116,embryonic hindlimb morphogenesis,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,TP63/CTNNB1,2
GO:0060252,positive regulation of glial cell proliferation,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,ETV5/EGFR,2
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,TGFB2/TAOK1,2
GO:0070723,response to cholesterol,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,INHBA/SMAD2,2
GO:1900048,positive regulation of hemostasis,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,SERPINE1/THBS1,2
GO:1900117,regulation of execution phase of apoptosis,2/87,21/13083,0.09523809523809523,14.32183908045977,4.9987433383205895,0.008456496058080241,0.03749994379124374,0.025056623233299765,DLC1/TP53BP2,2
GO:0061333,renal tubule morphogenesis,3/87,63/13083,0.047619047619047616,7.160919540229885,4.010533672697352,0.008462905975216888,0.03749994379124374,0.025056623233299765,MYC/FGF2/CTNNB1,3
GO:0071260,cellular response to mechanical stimulus,3/87,63/13083,0.047619047619047616,7.160919540229885,4.010533672697352,0.008462905975216888,0.03749994379124374,0.025056623233299765,GADD45A/FGF2/EGFR,3
GO:0150116,regulation of cell-substrate junction organization,3/87,63/13083,0.047619047619047616,7.160919540229885,4.010533672697352,0.008462905975216888,0.03749994379124374,0.025056623233299765,THBS1/DLC1/SMAD3,3
GO:0045860,positive regulation of protein kinase activity,5/87,189/13083,0.026455026455026454,3.9782886334610468,3.3743933035946116,0.008485281442073262,0.03753277928874734,0.025078563177908905,CCN1/TGFB2/FGF2/THBS1/EGFR,5
GO:0035050,embryonic heart tube development,3/87,64/13083,0.046875,7.049030172413793,3.9689787311235363,0.008837052718006335,0.03895136769202089,0.02602643220250871,SMAD3/CTNNB1/YAP1,3
GO:0071496,cellular response to external stimulus,3/87,64/13083,0.046875,7.049030172413793,3.9689787311235363,0.008837052718006335,0.03895136769202089,0.02602643220250871,GADD45A/FGF2/EGFR,3
GO:0002521,leukocyte differentiation,8/87,442/13083,0.01809954751131222,2.721797472304572,3.0129667035899517,0.009058700313633917,0.03985828137998924,0.026632411633065917,RUNX1/MYC/INHBA/SMAD7/RUNX2/CTNNB1/CREB1/SMARCA2,8
GO:0007292,female gamete generation,4/87,123/13083,0.032520325203252036,4.890384076254556,3.5467810651567517,0.009089972968171729,0.039925835734106296,0.026677549940693872,INHBA/HEXB/USP9X/CTNNB1,4
GO:0007517,muscle organ development,6/87,270/13083,0.022222222222222223,3.3417624521072797,3.1812013245455413,0.009156334567731163,0.03998220673615687,0.026715215782742274,CENPF/TGFB2/SMAD7/SMAD3/CTNNB1/CREB1,6
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,FGF2/THBS1,2
GO:0002719,negative regulation of cytokine production involved in immune response,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,TGFB2/SMAD7,2
GO:0010714,positive regulation of collagen metabolic process,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,RUNX1/INHBA,2
GO:0030325,adrenal gland development,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,SMAD2/SMAD3,2
GO:0032967,positive regulation of collagen biosynthetic process,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,RUNX1/INHBA,2
GO:0035988,chondrocyte proliferation,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,CCN2/SMAD7,2
GO:0048333,mesodermal cell differentiation,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,INHBA/SMAD1,2
GO:0071542,dopaminergic neuron differentiation,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,GSK3B/CTNNB1,2
GO:1900745,positive regulation of p38MAPK cascade,2/87,22/13083,0.09090909090909091,13.670846394984327,4.866543382014304,0.009262225723168718,0.03998220673615687,0.026715215782742274,GADD45B/GADD45A,2
GO:0051345,positive regulation of hydrolase activity,6/87,271/13083,0.02214022140221402,3.329431225346736,3.1704281877061162,0.009314788390632234,0.040140015951384264,0.026820660368758395,ASAP1/MYC/DLC1/TGM2/SMAD3/GSK3B,6
GO:0051054,positive regulation of DNA metabolic process,6/87,272/13083,0.022058823529411766,3.317190669371197,3.1597051268690715,0.009475200062034311,0.04076123800271364,0.027235747041181948,CDK1/MYC/FGF2/EGFR/CTNNB1/SMARCA2,6
GO:0051223,regulation of protein transport,7/87,357/13083,0.0196078431372549,2.9486139283299524,3.054258551097896,0.009590877684265003,0.041147155253023114,0.027493608311429857,PTPN14/CDK1/TGFB2/MDFIC/SMAD3/GSK3B/EGFR,7
GO:0071456,cellular response to hypoxia,4/87,125/13083,0.032,4.812137931034483,3.5038577957792514,0.009607164572112695,0.041147155253023114,0.027493608311429857,MYC/INHBA/NDRG1/DDAH1,4
GO:0009953,dorsal/ventral pattern formation,3/87,66/13083,0.045454545454545456,6.8354231974921635,3.8884876165020654,0.009614127981766963,0.041147155253023114,0.027493608311429857,SMAD2/CTNNB1/SMAD6,3
GO:0051336,regulation of hydrolase activity,8/87,448/13083,0.017857142857142856,2.685344827586207,2.9698328293275758,0.009780595694768301,0.04178830324102027,0.027922009048814013,ASAP1/MYC/SERPINE1/THBS1/DLC1/TGM2/SMAD3/GSK3B,8
GO:0045862,positive regulation of proteolysis,6/87,274/13083,0.021897810218978103,3.2929775987918446,3.138407463117928,0.00980194847163581,0.04180831082799764,0.027935377670684224,DAB2/MYC/DLC1/SMAD7/SMAD3/GSK3B,6
GO:0033627,cell adhesion mediated by integrin,3/87,67/13083,0.04477611940298507,6.733401955738548,3.8494871034547637,0.010017153727416298,0.042581392454847586,0.02845193351301828,SERPINE1/TGFB2/ITGB5,3
GO:0055006,cardiac cell development,3/87,67/13083,0.04477611940298507,6.733401955738548,3.8494871034547637,0.010017153727416298,0.042581392454847586,0.02845193351301828,CDK1/INHBA/JAG1,3
GO:0046639,negative regulation of alpha-beta T cell differentiation,2/87,23/13083,0.08695652173913043,13.076461769115442,4.742680709818744,0.010100830143278502,0.04268300964081509,0.028519831842599524,RUNX1/SMAD7,2
GO:0060441,epithelial tube branching involved in lung morphogenesis,2/87,23/13083,0.08695652173913043,13.076461769115442,4.742680709818744,0.010100830143278502,0.04268300964081509,0.028519831842599524,CTNNB1/YAP1,2
GO:1905207,regulation of cardiocyte differentiation,2/87,23/13083,0.08695652173913043,13.076461769115442,4.742680709818744,0.010100830143278502,0.04268300964081509,0.028519831842599524,TGFB2/EGFR,2
GO:0035107,appendage morphogenesis,4/87,127/13083,0.031496062992125984,4.736356231333152,3.4618361936097823,0.010143171350050158,0.04268300964081509,0.028519831842599524,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0035108,limb morphogenesis,4/87,127/13083,0.031496062992125984,4.736356231333152,3.4618361936097823,0.010143171350050158,0.04268300964081509,0.028519831842599524,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0051983,regulation of chromosome segregation,4/87,127/13083,0.031496062992125984,4.736356231333152,3.4618361936097823,0.010143171350050158,0.04268300964081509,0.028519831842599524,CDK1/CENPF/RAD18/SMARCA2,4
GO:0060560,developmental growth involved in morphogenesis,5/87,198/13083,0.025252525252525252,3.7974573319400906,3.2452316451879133,0.010248779943342895,0.04305517604339025,0.028768505104120403,SLIT2/USP9X/GSK3B/CTNNB1/YAP1,5
GO:0070374,positive regulation of ERK1 and ERK2 cascade,4/87,128/13083,0.03125,4.699353448275862,3.441152747698304,0.01041830989708232,0.04357383500189502,0.029115061413169167,CCN2/INHBA/FGF2/EGFR,4
GO:0001570,vasculogenesis,3/87,68/13083,0.04411764705882353,6.634381338742394,3.8112764774867602,0.010429899270373357,0.04357383500189502,0.029115061413169167,AMOT/CTNNB1/YAP1,3
GO:1903131,mononuclear cell differentiation,7/87,363/13083,0.01928374655647383,2.899876508026978,3.00349544025636,0.010450984165288295,0.04357383500189502,0.029115061413169167,RUNX1/MYC/INHBA/SMAD7/RUNX2/CTNNB1/SMARCA2,7
GO:0007163,establishment or maintenance of cell polarity,5/87,199/13083,0.02512562814070352,3.778374631779588,3.231348748338917,0.01045911031544689,0.04357383500189502,0.029115061413169167,AMOTL2/AMOTL1/GSK3B/AMOT/FAT1,5
GO:0060326,cell chemotaxis,5/87,199/13083,0.02512562814070352,3.778374631779588,3.231348748338917,0.01045911031544689,0.04357383500189502,0.029115061413169167,SERPINE1/TGFB2/FGF2/SLIT2/THBS1,5
GO:0042552,myelination,4/87,129/13083,0.031007751937984496,4.662924351777599,3.420682026346818,0.010698246707461,0.044422521096543356,0.02968213446894024,PMP22/NDRG1/HEXB/CTNNB1,4
GO:1903034,regulation of response to wounding,4/87,129/13083,0.031007751937984496,4.662924351777599,3.420682026346818,0.010698246707461,0.044422521096543356,0.02968213446894024,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0097194,execution phase of apoptosis,3/87,69/13083,0.043478260869565216,6.538230884557721,3.7738275335060787,0.010852407632387448,0.044988162548806145,0.030060083428900937,DLC1/TAOK1/TP53BP2,3
GO:0033674,positive regulation of kinase activity,5/87,201/13083,0.024875621890547265,3.7407788642991937,3.2038503719311557,0.01088863519972346,0.045063856569152544,0.030110660479346445,CCN1/TGFB2/FGF2/THBS1/EGFR,5
GO:0001945,lymph vessel development,2/87,24/13083,0.08333333333333333,12.531609195402298,4.626285418850655,0.010971846863559953,0.04518455161544887,0.030191306208257614,PTPN14/FGF2,2
GO:0031128,developmental induction,2/87,24/13083,0.08333333333333333,12.531609195402298,4.626285418850655,0.010971846863559953,0.04518455161544887,0.030191306208257614,FGF2/CTNNB1,2
GO:0044346,fibroblast apoptotic process,2/87,24/13083,0.08333333333333333,12.531609195402298,4.626285418850655,0.010971846863559953,0.04518455161544887,0.030191306208257614,MYC/TP63,2
GO:0007272,ensheathment of neurons,4/87,131/13083,0.030534351145038167,4.5917346670176356,3.3803628779417987,0.01127263689773689,0.04609458779971032,0.0307993720209598,PMP22/NDRG1/HEXB/CTNNB1,4
GO:0008366,axon ensheathment,4/87,131/13083,0.030534351145038167,4.5917346670176356,3.3803628779417987,0.01127263689773689,0.04609458779971032,0.0307993720209598,PMP22/NDRG1/HEXB/CTNNB1,4
GO:0001892,embryonic placenta development,3/87,70/13083,0.04285714285714286,6.444827586206897,3.7371134705013036,0.011284719660694631,0.04609458779971032,0.0307993720209598,CCN1/EGFR/STK3,3
GO:0071621,granulocyte chemotaxis,3/87,70/13083,0.04285714285714286,6.444827586206897,3.7371134705013036,0.011284719660694631,0.04609458779971032,0.0307993720209598,TGFB2/SLIT2/THBS1,3
GO:1902017,regulation of cilium assembly,3/87,70/13083,0.04285714285714286,6.444827586206897,3.7371134705013036,0.011284719660694631,0.04609458779971032,0.0307993720209598,ASAP1/GSK3B/YAP1,3
GO:0036294,cellular response to decreased oxygen levels,4/87,132/13083,0.030303030303030304,4.556948798328109,3.3605067720433897,0.011567150038084329,0.047171402106529266,0.03151887524284168,MYC/INHBA/NDRG1/DDAH1,4
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,3/87,71/13083,0.04225352112676056,6.354055366682855,3.701108802631468,0.011726874061699576,0.04757514944020197,0.03178865017577501,LATS2/GADD45A/EGFR,3
GO:0050821,protein stabilization,5/87,205/13083,0.024390243902439025,3.667788057190917,3.1498936544559597,0.011783670322623662,0.04757514944020197,0.03178865017577501,SMAD7/SMAD3/USP9X/CREB1/STK3,5
GO:0051222,positive regulation of protein transport,5/87,205/13083,0.024390243902439025,3.667788057190917,3.1498936544559597,0.011783670322623662,0.04757514944020197,0.03178865017577501,CDK1/TGFB2/SMAD3/GSK3B/EGFR,5
GO:0009954,proximal/distal pattern formation,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,TP63/CTNNB1,2
GO:0010092,specification of animal organ identity,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,FGF2/CTNNB1,2
GO:0010955,negative regulation of protein processing,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,SERPINE1/THBS1,2
GO:0035767,endothelial cell chemotaxis,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,FGF2/THBS1,2
GO:0036314,response to sterol,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,INHBA/SMAD2,2
GO:0044060,regulation of endocrine process,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,DAB2/INHBA,2
GO:0050820,positive regulation of coagulation,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,SERPINE1/THBS1,2
GO:1901889,negative regulation of cell junction assembly,2/87,25/13083,0.08,12.030344827586209,4.516610179661562,0.011874818002219472,0.04757514944020197,0.03178865017577501,THBS1/DLC1,2
GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,5/87,206/13083,0.024271844660194174,3.649983260796786,3.136615182845683,0.012015034724379961,0.048060138897519845,0.03211270927761756,TGFB2/FGF2/THBS1/EGFR/STK3,5
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,3/87,72/13083,0.041666666666666664,6.265804597701149,3.6657892771122054,0.012178907434271642,0.04856073107337564,0.03244719376681525,DAB2/SMAD7/GSK3B,3
GO:0046889,positive regulation of lipid biosynthetic process,3/87,72/13083,0.041666666666666664,6.265804597701149,3.6657892771122054,0.012178907434271642,0.04856073107337564,0.03244719376681525,DAB2/CCN1/CREB1,3
GO:0001894,tissue homeostasis,5/87,207/13083,0.024154589371980676,3.632350491420956,3.1234190171159777,0.012249478109591736,0.04868730760516018,0.03253176937270838,CCN2/EGFR/CTNNB1/WWTR1/YAP1,5
GO:0060249,anatomical structure homeostasis,5/87,207/13083,0.024154589371980676,3.632350491420956,3.1234190171159777,0.012249478109591736,0.04868730760516018,0.03253176937270838,CCN2/EGFR/CTNNB1/WWTR1/YAP1,5
GO:0030902,hindbrain development,4/87,135/13083,0.02962962962962963,4.455683269476373,3.302108329071225,0.012480310659665015,0.049448055504644324,0.03304008409443203,FGF2/DLC1/CTNNB1/SMAD1,4
GO:0048771,tissue remodeling,4/87,135/13083,0.02962962962962963,4.455683269476373,3.302108329071225,0.012480310659665015,0.049448055504644324,0.03304008409443203,RUNX1/JAG1/EGFR/CTNNB1,4
GO:0048661,positive regulation of smooth muscle cell proliferation,3/87,73/13083,0.0410958904109589,6.179971658006613,3.631131798292113,0.01264085430265905,0.049926397781210864,0.033359701698853224,FGF2/THBS1/EGFR,3
GO:0060021,roof of mouth development,3/87,73/13083,0.0410958904109589,6.179971658006613,3.631131798292113,0.01264085430265905,0.049926397781210864,0.033359701698853224,INHBA/TGFB2/SMAD2,3
